Please sign in to follow a disease.
Acute disease
MONDO:0020683Disease having a short and relatively severe course.
Also known as: acute disease, acute diseases, disease, acute
4144 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
Showing the 400 most recently updated of 890 trials in this tab.
-
Could a Lower-Dose polio vaccine help eradicate the disease?
⭐️ VACCINE ⭐️ CompletedThis study tests a hexavalent vaccine that protects against six diseases, including polio, but uses a lower dose of the inactivated polio vaccine (IPV). The goal is to see if this reduced-dose version works as well as the standard full-dose vaccine in infants. Around 1,500 health…
Phase: PHASE3 • Sponsor: Serum Institute of India Pvt. Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 03, 2026 00:00 UTC
-
New vaccine aims to protect infants from deadly diarrhea
⭐️ VACCINE ⭐️ CompletedThis study tests a new vaccine called Shigella4V, designed to protect against shigellosis, a severe diarrheal disease. Researchers are giving the vaccine to healthy adults, children, and 9-month-old infants to check its safety and whether it triggers a strong immune response. Dif…
Phase: PHASE1, PHASE2 • Sponsor: LimmaTech Biologics AG • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 14:03 UTC
-
New shigella vaccine shows promise in first human trials
⭐️ VACCINE ⭐️ CompletedThis study tested a new vaccine designed to protect against severe diarrhea caused by Shigella bacteria. The vaccine was first given to adults in Europe, then to adults, children, and infants in Africa. Researchers checked for side effects and measured immune responses to find th…
Phase: PHASE1, PHASE2 • Sponsor: GlaxoSmithKline • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 14:01 UTC
-
New vaccine aims to shield against multiple coronaviruses at once
⭐️ VACCINE ⭐️ CompletedThis study tested an experimental vaccine called VBI-2901a in 103 healthy adults aged 18-64 who had already received at least two doses of a licensed COVID-19 vaccine. The vaccine is designed to protect against three coronaviruses: SARS-CoV-2 (which causes COVID-19), SARS-CoV-1, …
Phase: PHASE1 • Sponsor: VBI Vaccines Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:31 UTC
-
Chinese COVID-19 vaccine trial shows strong immune response in 960 volunteers
⭐️ VACCINE ⭐️ CompletedThis Phase 2 trial tested the BNT162b2 mRNA vaccine in 960 healthy Chinese adults aged 18 to 85. Participants received two doses of either the vaccine or a placebo, 21 days apart. The main goal was to check safety and measure the immune response, specifically neutralizing antibod…
Phase: PHASE2 • Sponsor: BioNTech SE • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 11:03 UTC
-
Immune cells supercharged to fight cancer: early trial shows promise
Disease control CompletedThis early-phase trial tested whether giving patients their own natural killer (NK) cells, boosted by the drug bortezomib, is safe for treating advanced cancers like leukemia, lung, and pancreatic cancer. Thirty-five adults whose cancers had not responded to standard treatments r…
Phase: PHASE1 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New drug AZD9829 targets hard-to-treat blood cancers in early trial
Disease control CompletedThis study tests a new drug, AZD9829, in people with blood cancers that have come back or not responded to other treatments. The drug targets a protein called CD123 found on cancer cells. The main goals are to find a safe dose and check for side effects. About 56 adults will take…
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Blood-Filtering therapy may tame rare brain inflammation in children
Disease control CompletedThis trial investigates whether a blood-filtering procedure called immunoadsorption (IA), combined with the drug rituximab, can improve neurological function in children aged 0-18 with severe anti-NMDAR encephalitis. Participants receive 10 IA sessions over 28 days plus weekly ri…
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Fat stem cells infused into kidney artery to fight transplant rejection
Disease control CompletedThis early-stage trial tests whether a single infusion of stem cells from donated fat tissue can safely treat rejection in kidney transplant recipients. The cells are delivered directly into the kidney artery. The study includes 12 adults with biopsy-proven rejection and aims to …
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New drug aims to shield kidneys during heart surgery
Disease control CompletedThis study tests a single dose of ravulizumab given before heart surgery to see if it can prevent kidney damage and serious kidney problems in people with chronic kidney disease. About 736 adults will take part. The goal is to reduce the risk of major kidney events within 90 days…
Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New hope for frail AML patients: stronger chemo regimens tested
Disease control CompletedThis study tests whether giving full-strength chemotherapy (either CPX-351 or a combination called CLAG-M) can help medically less-fit adults with acute myeloid leukemia live longer and achieve remission. About 60 participants will receive one of the two treatments. The goal is t…
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New drug targets genetic weakness in Hard-to-Treat blood cancers
Disease control CompletedThis study tests a drug called FT-2102 (olutasidenib) in people with acute myeloid leukemia or myelodysplastic syndrome whose cancers have a specific IDH1 gene mutation. The drug is given alone or combined with standard chemotherapy drugs (azacitidine or cytarabine). The goal is …
Phase: PHASE1, PHASE2 • Sponsor: Forma Therapeutics, Inc. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New pill shows promise for Hard-to-Treat blood cancers in japanese patients
Disease control CompletedThis study tests a drug called acalabrutinib in Japanese adults with advanced B-cell blood cancers (like leukemia and lymphoma). The goal is to see if it is safe and helps control the cancer. Participants take the drug daily, and researchers monitor side effects and how well the …
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Immunotherapy blinatumomab shows promise in kids with relapsed leukemia
Disease control CompletedThis Phase 3 trial tested the drug blinatumomab in 111 children with high-risk relapsed B-precursor acute lymphoblastic leukemia (ALL). Blinatumomab is an immunotherapy that helps the body's immune cells attack cancer cells. The study compared blinatumomab to standard chemotherap…
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Can nivolumab rescue patients when CAR T-Cell therapy fails?
Disease control CompletedThis phase 2 trial tested nivolumab, an immunotherapy drug, in 20 people with blood cancers like lymphoma, leukemia, or myeloma that came back or didn't respond after CAR T-cell therapy. The goal was to see if nivolumab could help the immune system attack the cancer again. The st…
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Could a pill keep AML at bay? new study tests maintenance therapy after chemo
Disease control CompletedThis study looked at whether taking oral azacitidine (Onureg) as maintenance therapy can help older adults with acute myeloid leukemia (AML) stay in remission longer after treatment with CPX-351 chemotherapy. The study included 100 patients aged 65 and older who had achieved remi…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Remote Check-Ups may be safe for heart patients after a heart attack
Disease control CompletedThis study looked at whether follow-up visits by phone or video are as safe as in-person visits for people who had a heart attack and received a stent. 88 patients were split into two groups: one had telemedicine check-ups at 1, 3, and 6 months, and the other had standard office …
Phase: NA • Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Chemotherapy showdown: which combo works best for T-Cell cancers in kids?
Disease control CompletedThis large phase 3 trial studied nearly 1,900 children and young adults with newly diagnosed T-cell acute lymphoblastic leukemia or T-cell lymphoblastic lymphoma. Researchers compared different chemotherapy combinations, including varying doses of methotrexate and adding the drug…
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Balloon treatment aims to defuse 'Time Bomb' plaques in heart arteries
Disease control CompletedThis study tested whether a drug-coated balloon can stabilize fatty plaques in heart arteries that are at risk of rupturing and causing a heart attack. Researchers treated 45 patients with a recent heart condition, using a special balloon to deliver medication directly to the pla…
Phase: NA • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Immunotherapy combo shows promise for Tough-to-Treat blood cancers
Disease control CompletedThis phase 2 trial tested the immunotherapy drug pembrolizumab (Keytruda) alone or combined with idelalisib or ibrutinib in 65 patients with chronic lymphocytic leukemia (CLL) or low-grade B-cell non-Hodgkin lymphoma (NHL) that had returned or stopped responding to treatment. The…
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New drug cocktail shows promise for Tough-to-Treat leukemia in seniors
Disease control CompletedThis study tested a chemotherapy drug called CPX-351 in 59 adults aged 60 to 75 with a high-risk form of acute myeloid leukemia (AML). The goal was to see how well it could put the cancer into remission. Participants received the drug through an IV, and some also had a stem cell …
Phase: PHASE2 • Sponsor: PETHEMA Foundation • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could a targeted drug keep AML in check?
Disease control CompletedThis phase III trial tests whether the drug tipifarnib can prevent acute myeloid leukemia (AML) from coming back in patients who are already in remission. Participants include adults over 60 in first remission, those in second or later remission, or those who achieved remission a…
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Heart attack drug combo may unclog arteries when standard methods fail
Disease control CompletedThis completed trial tested whether giving epinephrine and verapamil directly into the heart arteries could help restore blood flow in heart attack patients whose vessels remain blocked despite standard treatment. 104 adults with ST-elevation heart attacks were enrolled. The stud…
Phase: NA • Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Targeted therapy combo aims to improve survival in older leukemia patients
Disease control CompletedThis study tests whether adding the targeted drug inotuzumab ozogamicin to a milder chemotherapy regimen improves survival in adults over 55 with a specific type of acute lymphoblastic leukemia (ALL) that is Philadelphia chromosome-negative and CD22-positive. Participants receive…
Phase: PHASE2 • Sponsor: Versailles Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Triple-Drug cocktail aims to boost remission in acute myeloid leukemia
Disease control CompletedThis phase 3 trial is testing whether a combination of three drugs—azacitidine, venetoclax, and ATRA—can safely and effectively treat adults newly diagnosed with acute myeloid leukemia (AML). The drugs work together to stop cancer cell growth by demethylating DNA, promoting cell …
Phase: PHASE3 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Experimental pill targets Hard-to-Treat blood cancers
Disease control CompletedThis study tested a daily pill called E7820 in 12 adults with relapsed or treatment-resistant acute myeloid leukemia, myelodysplastic syndromes, or chronic myelomonocytic leukemia. All participants had specific mutations in splicing factor genes. The goal was to see if the drug c…
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a Clot-Busting drug boost heart attack recovery?
Disease control CompletedThis study tested whether giving a low dose of the clot-busting drug tPA directly into the heart arteries, during standard angioplasty, improves blood flow and reduces complications in people having a major heart attack. 210 patients were enrolled. The goal was to see if this app…
Phase: PHASE3 • Sponsor: Population Health Research Institute • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a cannabidiol drug help heal inflamed hearts?
Disease control CompletedThis trial tests whether CardiolRx, a pharmaceutical cannabidiol, can improve heart recovery in adults with acute myocarditis (heart muscle inflammation). Participants receive either CardiolRx or a placebo for 12 weeks. The study uses heart MRI scans to measure changes in heart t…
Phase: PHASE2 • Sponsor: Cardiol Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Experimental drug RAD001 tested for tough leukemias and lymphomas
Disease control CompletedThis study tested the drug RAD001 (everolimus) in 29 patients with relapsed or hard-to-treat blood cancers like leukemia, lymphoma, and myelofibrosis. The goal was to find the safest highest dose and see if it helps control the disease. It was a small early-phase trial at a singl…
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug combo shows promise for leukemia patients
Disease control CompletedThis early-phase study tested a combination of two drugs, daratumumab and ibrutinib, in 15 people with untreated chronic lymphocytic leukemia (CLL) who needed therapy. The goal was to see if the combination is safe and how well it works at controlling the disease. Participants re…
Phase: PHASE1 • Sponsor: Jennifer Woyach • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Kidney alert team may cut deaths in hospital patients
Disease control CompletedThis study tested whether quickly alerting a kidney specialist team when hospitalized patients show signs of severe kidney disease could improve survival. Over 1,100 patients in France were included. The team of a nephrologist and pharmacist would help manage care during the hosp…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Baking soda treatment tested for ICU kidney patients
Disease control CompletedThis study tested whether giving sodium bicarbonate (a common substance that neutralizes acid) to critically ill patients with severe metabolic acidosis and moderate-to-severe acute kidney injury could improve survival at 90 days. The trial enrolled 640 adults in the ICU who had …
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a Weight-Loss pill also crush kidney stones?
Disease control CompletedThis pilot study tested whether a combination of phentermine and topiramate, two drugs used for weight loss, could help shrink uric acid kidney stones in obese people with type 2 diabetes or pre-diabetes. Nineteen participants were randomly assigned to receive the drug combo or c…
Phase: PHASE2 • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a mask prevent breathing failure in obese ICU patients?
Disease control CompletedThis study looked at whether using a non-invasive ventilation (NIV) mask right after removing a breathing tube can prevent respiratory failure in obese intensive care patients. About 1000 obese adults were randomly assigned to receive either NIV or oxygen therapy. The goal was to…
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could poison gas heal lungs? small trial tests carbon monoxide for ARDS
Disease control CompletedThis phase II trial tested whether inhaling low doses of carbon monoxide (200 ppm for 90 minutes daily for 3 days) is safe and helpful for people with acute respiratory distress syndrome (ARDS), a severe lung condition. Only 4 intubated adults participated, making this a very sma…
Phase: PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could an Immune-Modulating drug slow early Alzheimer's?
Disease control CompletedThis phase 2 trial investigates whether lenalidomide, a drug that calms inflammation, can slow cognitive decline in people with mild cognitive impairment due to Alzheimer's disease. Participants take lenalidomide or a placebo for up to 12 months, followed by a 6-month washout per…
Phase: PHASE2 • Sponsor: St. Joseph's Hospital and Medical Center, Phoenix • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
Real-World data suggests asciminib may help some leukemia patients
Disease control CompletedThis study reviewed medical records of 37 adults with Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL) who took asciminib because other treatments stopped working or caused side effects. Researchers wanted to see how many patients achieved complete remission within th…
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
Could one day of antibiotics be enough for bile duct infections?
Disease control CompletedThis study looked at 410 patients with a bile duct infection (cholangitis) who had a procedure to drain the bile duct. It compared giving antibiotics for just 1 day versus the usual 4 to 7 days. The goal was to see if the shorter course is just as good at curing the infection, wh…
Phase: NA • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Can a single drug save rejected kidneys? new trial investigates
Disease control CompletedThis study tested whether adding the drug rituximab to standard care could stop acute rejection in kidney transplant patients. 40 adults who had a kidney transplant within the past year and showed signs of acute humoral rejection took part. The main goal was to see if rituximab c…
Phase: PHASE3 • Sponsor: University Hospital, Tours • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New drug shows promise in controlling transplant complications
Disease control CompletedThis study tested a new drug called EQ001 in 30 people who developed acute graft-versus-host disease (aGVHD) after a stem cell transplant. aGVHD is a serious condition where donor immune cells attack the patient's body. The goal was to see if EQ001 is safe and can help control th…
Phase: PHASE1, PHASE2 • Sponsor: Biocon Limited • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Could a simple tablet stop Travelers' diarrhea before it starts?
Disease control CompletedThis study tested whether a daily dose of Travelan (IMM-124E) tablets could prevent moderate-to-severe diarrhea in healthy adults deliberately infected with ETEC bacteria, a common cause of travelers' diarrhea. Sixty-three volunteers took either Travelan or a placebo for 7 days. …
Phase: PHASE2 • Sponsor: Immuron Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Chemotherapy-Free combo aims to boost remission in younger AML patients
Disease control CompletedThis phase 2 trial is testing whether a combination of two drugs, venetoclax and azacitidine, can effectively treat adults aged 18 to 59 who have been newly diagnosed with acute myeloid leukemia (AML) and have not yet received any treatment. Participants take both drugs in cycles…
Phase: PHASE2 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New study tests safer sedation for tiny lungs
Disease control CompletedThis study looked at whether giving a sedative called propofol to very premature babies (under 32 weeks) before a less invasive breathing treatment (LISA) is safe and reduces the need for a breathing machine. The trial involved 233 infants with breathing problems. Researchers com…
Phase: PHASE3 • Sponsor: University Hospital, Grenoble • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Could a common diabetes drug help kidneys in sepsis?
Disease control CompletedThis study tested whether metformin, a common diabetes drug, is safe and practical to use for treating acute kidney injury caused by sepsis. Researchers gave low-dose metformin to 80 ICU patients with sepsis and kidney injury, monitoring for side effects and feasibility. The goal…
Phase: PHASE2 • Sponsor: Hernando Gomez • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New drug combo shows promise for tough leukemia cases
Disease control CompletedThis phase 2 trial tested a combination of two drugs, ibrutinib and blinatumomab, in 19 adults with B-cell acute lymphoblastic leukemia that had come back or wasn't responding to treatment. The goal was to see how many patients achieved complete remission. The study is completed,…
Phase: PHASE2 • Sponsor: University of California, Davis • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New combo therapy shows promise for hard-to-treat leukemia
Disease control CompletedThis early-phase trial tested whether adding the drug uproleselan to standard chemotherapy (cladribine and low-dose cytarabine) could help people with treated secondary acute myeloid leukemia (AML). Secondary AML is a type of leukemia that develops after treatment for another bon…
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New pill could shield heart attack survivors from future clots
Disease control CompletedThis large phase 3 study tested whether milvexian, an oral blood thinner, can reduce the risk of major cardiovascular events like heart attack, stroke, or death in people who recently had an acute coronary syndrome (heart attack or unstable angina). Over 14,000 participants took …
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New liposome combo shows promise for Tough-to-Treat leukemia
Disease control CompletedThis study tested a new formulation of two chemotherapy drugs (CPX-351) in 56 adults with newly diagnosed acute myeloid leukemia (AML) who were at high risk of not responding to standard treatment. The goal was to find the best dose and see how well it worked to stop cancer cells…
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Can antibody infusions shield CLL patients from deadly infections?
Disease control CompletedThis study tested whether regular infusions of Panzyga (a concentrated antibody solution from donated blood) could prevent serious infections in people with chronic lymphocytic leukemia (CLL) who also have low antibody levels. The trial included 247 adults with CLL who were recei…
Phase: PHASE3 • Sponsor: Octapharma • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New drug cocktail shows promise against tough leukemia
Disease control CompletedThis study tested a combination of three drugs (decitabine, venetoclax, and ponatinib) in 20 adults with a rare, aggressive leukemia called Philadelphia chromosome-positive acute myeloid leukemia or chronic myelogenous leukemia in blast phase. The goal was to see if the drugs cou…
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Can a dialysis-like treatment save kids with lung failure after transplant?
Disease control CompletedThis study tested whether early hemofiltration, a continuous dialysis procedure, could improve survival in children who develop respiratory failure after a bone marrow transplant. Only 6 children took part. The idea was to filter out inflammatory molecules that drive lung damage.…
Phase: PHASE2, PHASE3 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New drug combo shrinks spleens in bone marrow cancer patients
Disease control CompletedThis study tested a new drug called pelabresib in people with certain blood cancers, including myelofibrosis and leukemia. In the first part, the drug was given alone to find the safest dose. In the second part, it was given with or without another drug (ruxolitinib) to see if it…
Phase: PHASE1, PHASE2 • Sponsor: Constellation Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New dialysis technique may help critically ill patients stay stable
Disease control CompletedThis study looked at 120 critically ill patients with acute kidney injury and shock who needed dialysis. Researchers compared a special method called sodium profiling dialysis to standard dialysis to see if it helped keep blood pressure stable and reduced fluid buildup in the lun…
Sponsor: Fayoum University • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New hope for tough leukemia: targeted drug combo shows promise in large trial
Disease control CompletedThis large phase III trial tested whether adding the targeted drug dasatinib to standard chemotherapy improves outcomes for children and young adults with newly diagnosed high-risk B-cell acute lymphoblastic leukemia (B-ALL), including those with certain genetic mutations. Nearly…
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Could a Gene-Targeting drug boost chemo for older leukemia patients?
Disease control CompletedThis study tested whether adding a drug called oblimersen to standard chemotherapy (daunorubicin and cytarabine) helps older adults (60+) with untreated acute myeloid leukemia live longer or achieve remission. About 500 participants were randomly assigned to receive chemo with or…
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Blood test could help kids avoid harmful steroid side effects after transplant
Disease control CompletedThis study tested whether a blood test (GVHD biomarkers) can help doctors safely reduce steroid doses in children with graft-versus-host disease (GVHD) after a bone marrow transplant. Fifty children with newly diagnosed GVHD received prednisone, and those with low biomarker level…
Phase: PHASE2 • Sponsor: John Levine • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
One cord blood unit may replace two in stem cell transplants for blood cancer
Disease control CompletedThis study tested a new way to treat blood cancers like leukemia in 16 adults who did not have a standard bone marrow donor. Doctors used a single unit of cord blood that was grown in a lab to increase the number of stem cells before transplant. The goal was to see if this method…
Phase: PHASE2 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New drug may tame Life-Threatening side effects of cancer immunotherapy
Disease control CompletedThis study tested whether the drug siltuximab can lessen the severity of cytokine release syndrome (CRS) and neurological side effects (ICANS) that often occur after CAR-T cell therapy for blood cancers like lymphoma and leukemia. Twenty-four participants received siltuximab alon…
Phase: PHASE2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New combo therapy aims to improve survival in aggressive leukemia
Disease control CompletedThis large phase III trial tested whether adding the drugs bortezomib and sorafenib to standard chemotherapy helps people with newly diagnosed acute myeloid leukemia (AML) live longer without the cancer returning. Over 1,600 participants took part. The study focused on patients w…
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Short-Term stronger blood thinner may cut heart risks in AF patients
Disease control CompletedThis study tested whether giving a more powerful antiplatelet drug (prasugrel or ticagrelor) for one month after a heart attack, along with a standard blood thinner, could reduce heart attacks, strokes, and deaths in people with atrial fibrillation. The 602 participants were then…
Phase: PHASE4 • Sponsor: Ludwig-Maximilians - University of Munich • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Intense Pre-Transplant combo shows promise for tough leukemias
Disease control CompletedThis phase 2 trial tested a combination of intravenous busulfan, etoposide, and low-dose total-body irradiation before a donor stem cell or bone marrow transplant in 30 patients with advanced leukemia or myelodysplastic syndromes. The goal was to see how well this regimen control…
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Selective immune cell removal may tame transplant complications
Disease control CompletedThis study tested whether removing a specific type of immune cell (naïve T cells) from donor stem cell grafts could prevent graft-versus-host disease (GVHD) after a stem cell transplant for blood cancers. The trial enrolled 84 patients who received high- or medium-intensity chemo…
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Experimental enzyme shot aims to rescue kidneys in sepsis patients
Disease control CompletedThis study tested a single intravenous dose of TIN816, an enzyme that breaks down ATP to reduce inflammation, in 316 ICU patients with sepsis-related acute kidney injury. The goal was to see if it improves kidney function over 8 days and reduces major kidney problems by day 90. T…
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Heart attack patients: which blood thinner is safer?
Disease control CompletedThis study looked at over 17,000 people who had a heart attack to compare two blood thinners: prasugrel and ticagrelor. Hospitals switched from ticagrelor to prasugrel in a stepwise way to see which drug better prevents death, another heart attack, or stroke. The goal is to find …
Phase: PHASE4 • Sponsor: Vastra Gotaland Region • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New combo shows promise for High-Risk leukemia patients
Disease control CompletedThis study tested a new treatment for adults with a high-risk form of acute promyelocytic leukemia (APL). The experimental therapy combined arsenic trioxide, ATRA, and a low dose of idarubicin, aiming to improve survival and reduce side effects compared to the standard chemothera…
Phase: PHASE3 • Sponsor: Technische Universität Dresden • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Protein and exercise combo tested to fight muscle loss in sick kids
Disease control CompletedThis pilot study tested whether giving critically ill children on breathing machines extra protein along with a personalized exercise program could help preserve muscle mass and improve recovery. The trial enrolled 18 children in the ICU and measured how feasible and safe the app…
Phase: NA • Sponsor: Boston Children's Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Can a biomarker predict who responds to a new AML combo?
Disease control CompletedThis phase 2 trial tested whether certain biomarkers in bone marrow can predict how well patients with high-risk acute myeloid leukemia (AML) respond to treatment with sirolimus plus standard chemotherapy (MEC). The study enrolled 39 adults with AML that was hard to treat or had …
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Massive trial seeks best chemo cocktail for kids with leukemia
Disease control CompletedThis large phase 3 trial enrolled over 9,000 children with newly diagnosed standard-risk B-ALL or localized B-LLy. Researchers tested different combinations and doses of chemotherapy drugs to see which worked best with the fewest side effects. The goal was to improve disease-free…
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
New pill aims to keep leukemia at bay after transplant
Disease control CompletedThis early-phase trial tested a drug called ONC-201 in 20 people with high-risk acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) who had recently received a stem cell transplant. Participants took the drug by mouth once a week for a year to see if it was safe and co…
Phase: PHASE1 • Sponsor: University of Nebraska • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New drug combo may make cord blood transplants safer for blood cancer patients
Disease control CompletedThis study tested whether adding the drug tocilizumab to standard care could reduce the risk of graft-versus-host disease (GVHD) after a cord blood transplant in adults with blood cancers. GVHD is a serious complication where donor cells attack the patient's body. Tocilizumab blo…
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New chemo cocktail aims to beat back leukemia relapse
Disease control CompletedThis phase 2 trial tests whether a combination of clofarabine and intermediate-dose cytarabine (CLARA) works better than high-dose cytarabine (HDAC) alone as consolidation therapy for younger adults (18-60) with newly diagnosed acute myeloid leukemia (AML). After initial remissio…
Phase: PHASE2 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New lupus drug candidate BMS-986326 enters early human testing
Disease control CompletedThis early-phase study tested a new drug called BMS-986326 in 45 adults with different forms of lupus, including skin and systemic lupus. The main goal was to check safety and how the body processes the drug, not yet to see if it works. Participants received either the drug or a …
Phase: PHASE1 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Could a single drug infusion limit permanent heart damage during a heart attack?
Disease control CompletedThis study tested whether a drug called dexrazoxane, given through a vein, can reduce permanent heart muscle damage in people having a severe heart attack (STEMI). Fifty adults received either the drug or a placebo during their standard stent procedure. The goal was to see if the…
Phase: PHASE2 • Sponsor: Rohan Dharmakumar • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Engineered immune cells take aim at tough childhood cancers
Disease control CompletedThis early-phase trial tested whether a new type of immune cell therapy (CD22 CAR T cells) could be safely made and given to 10 children and young adults whose B-cell leukemia or lymphoma had come back or stopped responding to treatment. The therapy uses the patient's own immune …
Phase: PHASE1 • Sponsor: Kara Lynn Davis • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New antibiotic combo shows promise against tough UTIs
Disease control CompletedThis study tested a new antibiotic combination, cefepime-zidebactam, against a standard antibiotic (meropenem) in adults hospitalized with complicated urinary tract infections or kidney infections. About 530 participants received either the new drug or the standard one for 7 to 1…
Phase: PHASE3 • Sponsor: Wockhardt • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Oxygen boost after heart attack shows promise in small study
Disease control CompletedThis study tested a new way to give extra oxygen to the heart after a heart attack. Twenty patients received a special oxygen treatment for one hour through a thin tube placed in the heart artery. The main goal was to see if the procedure was safe and could be done without proble…
Phase: NA • Sponsor: TherOx • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New hope for tough MDS: drug trio targets resistant cancer cells
Disease control CompletedThis study tested a three-drug combination (navitoclax, venetoclax, and decitabine) in 6 adults with high-risk myelodysplastic syndrome (MDS) that came back or didn't respond to standard therapy. The goal was to find the safest dose and see if the combo could shrink or control th…
Phase: PHASE1 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New hope for kids with tough leukemia: experimental combo tested
Disease control CompletedThis early-phase study tested a combination of three chemotherapy drugs (CPX-351 and gemtuzumab ozogamicin) in children whose acute myeloid leukemia (AML) had come back or didn't respond to standard treatment. The main goals were to find the best dose and check for side effects. …
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New hope for AML patients: drug combo targets leukemia cells
Disease control CompletedThis study tested a new drug called S65487, which blocks a protein that helps leukemia cells survive, combined with the standard drug azacitidine. The trial included 57 adults with untreated acute myeloid leukemia who were not healthy enough for intensive chemotherapy. Researcher…
Phase: PHASE1, PHASE2 • Sponsor: Institut de Recherches Internationales Servier • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Next-Day clinic aims to cut hospital admissions for common ailments
Disease control CompletedThis study tested a new clinic that sees emergency room patients the next day for conditions like pneumonia, heart failure, and kidney injury. The goal was to avoid hospital stays and improve patient care. About 570 adults took part, and researchers measured how many days they we…
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
One pill to rule them all? polypill aims to boost heart drug adherence
Disease control CompletedThis completed Phase 2 trial tested whether a single daily polypill (containing a statin, aspirin, and a blood thinner) could improve medication adherence in 140 patients who had a heart attack and received a stent. The study compared the polypill to usual care with separate pill…
Phase: PHASE2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Early trial checks safety of blinatumomab in japanese leukemia patients
Disease control CompletedThis early-phase study tested the safety of the drug blinatumomab (Blincyto®) in 6 Japanese adults newly diagnosed with a type of leukemia called B-ALL. The main goal was to see what side effects occurred. Researchers also looked at how the drug moves through the body and whether…
Phase: PHASE1 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Calquence capsules pass Real-World safety check in CLL patients
Disease control CompletedThis completed study looked at the safety of Calquence (acalabrutinib) capsules in 67 people with previously untreated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma. Researchers tracked side effects like infections and bone marrow problems during everyday use. …
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Promising combo tackles FLT3 leukemia in early trial
Disease control CompletedThis early-phase study tested whether adding two targeted drugs, gemtuzumab ozogamicin and midostaurin, to standard chemotherapy is safe for people with a newly diagnosed, aggressive form of acute myeloid leukemia (AML) that has a FLT3 mutation. The trial enrolled 21 adults and a…
Phase: PHASE1 • Sponsor: Uma Borate • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Early trial explores new drug for blood cancers in japanese patients
Disease control CompletedThis early-phase study tested a new drug called nemtabrutinib in 7 Japanese adults with certain blood cancers (like chronic lymphocytic leukemia). The main goals were to check the drug's safety and how the body processes it. Researchers looked for side effects and measured drug l…
Phase: PHASE1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Oxygen showdown: tight vs. liberal targets in heart failure
Disease control CompletedThis study tested whether giving heart failure patients with fluid in their lungs a lower oxygen target (90% oxygen saturation) or a higher one (96%) leads to better outcomes. 122 patients were randomly assigned to one of the two groups in the emergency department. The goal was t…
Phase: PHASE2, PHASE3 • Sponsor: Copenhagen University Hospital, Hvidovre • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New combo therapy shows promise for Hard-to-Treat blood cancers
Disease control CompletedThis study tested a combination of two drugs, acalabrutinib and pembrolizumab, in 161 people with various blood cancers such as lymphoma, leukemia, and multiple myeloma. The main goal was to check safety and side effects, while also seeing if the tumors shrank. The approach aims …
Phase: PHASE1, PHASE2 • Sponsor: Acerta Pharma BV • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Immunotherapy combo shows promise for Post-Transplant leukemia relapse
Disease control CompletedThis phase 1 trial tested two immunotherapy drugs, nivolumab and ipilimumab, in 29 patients whose acute myeloid leukemia or myelodysplastic syndrome came back or did not respond after a donor stem cell transplant. The goal was to find the safest dose and see if the drugs could he…
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Anesthesia choice may boost kidney transplant success
Disease control CompletedThis study tested whether using sevoflurane gas for anesthesia during kidney transplant surgery helps the new kidney recover faster than standard propofol anesthesia. 120 adults receiving a kidney transplant were randomly assigned to one of the two anesthetics. Researchers tracke…
Phase: PHASE3 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New hope for older AML patients: triple drug combo aims to control disease and prevent relapse
Disease control CompletedThis study tested a combination of three drugs (low-dose cytarabine or azacitidine, plus venetoclax and quizartinib) in 113 adults aged 60 and older with newly diagnosed acute myeloid leukemia (AML) who were not eligible for standard chemotherapy. The goal was to quickly control …
Phase: PHASE1, PHASE2 • Sponsor: PETHEMA Foundation • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Experimental drug aims to help ARDS patients breathe easier
Disease control CompletedThis Phase 2 trial tested whether adding reparixin, an anti-inflammatory drug, to standard care could improve lung function in adults with moderate to severe acute respiratory distress syndrome (ARDS). The study enrolled 66 patients on mechanical ventilators. Researchers measured…
Phase: PHASE2 • Sponsor: Dompé Farmaceutici S.p.A • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Lifting weights to fight transplant After-Effects: a new hope for young survivors
Disease control CompletedThis study looked at whether a 16-week strength training program can prevent or reduce late effects like muscle loss, heart disease, and diabetes in adults who had a bone marrow transplant as children. 28 survivors and a matched control group participated. The goal was to see if …
Phase: NA • Sponsor: Rigshospitalet, Denmark • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Experimental drug combo targets tough blood cancers
Disease control CompletedThis early-stage trial tested a new drug called INCB040093, alone or combined with itacitinib, in 121 adults with B-cell cancers that had come back or stopped responding to treatment. The main goal was to find safe doses and check for side effects. Researchers also looked for sig…
Phase: PHASE1 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New monitoring technique may shield kidneys during liver surgery
Disease control CompletedThis study tested a new way to monitor kidney oxygen levels during liver surgery to try to prevent acute kidney injury (AKI). 80 adults having liver surgery were randomly assigned to either standard care or extra monitoring that triggered a step-by-step treatment plan if oxygen l…
Phase: PHASE1 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New triple-drug combo shows promise for hard-to-treat leukemia patients
Disease control CompletedThis early-phase study tested a new drug called siremadlin added to two existing drugs (venetoclax and azacitidine) for adults with acute myeloid leukemia (AML) who are too frail for standard chemotherapy. The study included 14 people whose cancer did not respond well to initial …
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New anticoagulation strategy tested for dialysis circuits in ECMO patients
Disease control CompletedThis study tested whether adding regional citrate anticoagulation (RCA) to standard heparin can reduce clotting in continuous kidney dialysis circuits for patients on ECMO. Eighteen ICU adults with ARDS and acute kidney injury were enrolled. Each patient received alternating peri…
Phase: NA • Sponsor: University of Milano Bicocca • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New endoscopic procedure may offer better Long-Term relief for gallbladder patients too sick for surgery
Disease control CompletedThis study looked at 484 high-risk surgical patients with acute cholecystitis (gallbladder inflammation) who first received a standard drainage tube through the skin. Some then had a newer procedure using an endoscope to place a metal stent inside the gallbladder. Researchers com…
Sponsor: University of Bologna • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New blood filter may boost survival in septic shock patients on dialysis
Disease control CompletedThis study looked back at 400 critically ill patients with septic shock and kidney failure who needed dialysis. Researchers compared those who received a special filter (Oxiris) that removes toxins and inflammation-causing substances to those who got standard filters. The goal wa…
Sponsor: Clinica Universidad de Navarra, Universidad de Navarra • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Pill may replace shots for blood cancer patients, study finds
Disease control CompletedThis study tested whether an oral medication (CC-486) could help elderly patients with a serious blood disorder called myelodysplastic syndrome (MDS) maintain their improvement after initial injectable treatment. Eleven patients who had responded to injectable azacitidine switche…
Phase: PHASE2 • Sponsor: University of Florence • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New hope for tough blood cancers? early trial tests LYT-200
Disease control CompletedThis early-stage study tested a new drug called LYT-200 in 101 adults whose acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS) had come back or stopped responding to treatment. The main goals were to check the drug's safety and find the right dose. While not…
Phase: PHASE1 • Sponsor: PureTech • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New drug shows promise for ARDS patients in major trial
Disease control CompletedThis clinical trial tested a drug called sivelestat sodium in 324 adults with acute respiratory distress syndrome (ARDS) and systemic inflammation. The drug aims to block a harmful enzyme that damages lung tissue. Researchers measured whether it improved oxygen levels and reduced…
Phase: PHASE4 • Sponsor: Sichuan Provincial People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Experimental combo targets stubborn leukemia in tiny trial
Disease control CompletedThis early-phase trial tested a combination of two drugs, enasidenib and cobimetinib, in just 3 patients with a specific form of acute myeloid leukemia (AML) that had come back or didn't respond to treatment. The goal was to see if the combination was safe and to find the best do…
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New combo attack on lymphoma shows promise in early trial
Disease control CompletedThis early-phase trial tested a three-part treatment for non-Hodgkin lymphoma: freezing tumors (cryoablation), injecting a personalized dendritic cell vaccine made from the patient's own cells, and giving the immunotherapy drug pembrolizumab (Keytruda). The goal was to find the s…
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New drug cocktail aims to cut bleeding and heart attacks in atrial fibrillation patients
Disease control CompletedThis study tested a combination of two drugs, rivaroxaban and ticagrelor, in 40 patients with atrial fibrillation who had a stent placed. The goal was to see if this combo causes less bleeding and prevents heart attacks or strokes better than current treatments. Patients took the…
Phase: PHASE3 • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Cholesterol drug may calm inflammation after heart attack
Disease control CompletedThis study tested whether evolocumab (Repatha), a drug that lowers LDL cholesterol, can reduce inflammation and improve heart function in people who recently had a mild heart attack (NSTEMI). Sixty participants received either evolocumab or a placebo within 24 hours of admission.…
Phase: PHASE2 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New pill shows promise against tough blood cancers
Disease control CompletedThis early-stage trial tested an oral drug called NTX-301 in 22 adults with certain blood cancers (MDS, AML, or CMML) that had not responded to prior treatments. The main goal was to check safety and find the right dose. Researchers also looked for signs that the drug might help …
Phase: PHASE1 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Can a gout drug cool down artery inflammation in diabetics?
Disease control CompletedThis study tested whether colchicine, a drug used for gout, can reduce inflammation in the arteries of people with diabetes who recently had a heart attack or stroke. Researchers used a special PET scan to measure inflammation in the blood vessels. 115 participants were randomly …
Phase: PHASE3 • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New study checks bleeding risk when CLL drug meets blood thinners
Disease control CompletedThis study observed 45 people with chronic lymphocytic leukemia (CLL) who were taking the drug acalabrutinib (Calquence) along with a direct oral anticoagulant (DOAC), a type of blood thinner. The main goal was to see how many patients had serious bleeding events while on this co…
Sponsor: iOMEDICO AG • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Could donor cells beat a deadly brain virus?
Disease control CompletedThis early-phase study tested whether infusing virus-fighting immune cells from a healthy donor could safely treat progressive multifocal leukoencephalopathy (PML), a serious brain infection in people with weak immune systems. Sixty adults with PML received up to three infusions …
Phase: EARLY_PHASE1 • Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Experimental cell treatment shows promise for COVID-19 lung failure
Disease control CompletedThis early-stage study tested a single dose of mesenchymal stromal cells in 7 COVID-19 patients with severe acute respiratory distress syndrome (ARDS) who were on ventilators. The main goal was to check safety, looking for serious side effects like heart problems or blood clots w…
Phase: PHASE1 • Sponsor: Uppsala University • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Stem cell transplant study seeks best way to prevent immune attack
Disease control CompletedThis study tested different drug combinations to prevent graft-versus-host disease (GVHD) in 174 people with blood cancers receiving stem cells from an unrelated donor. GVHD is a serious side effect where donor cells attack the patient's body. The goal was to find which drug regi…
Phase: PHASE3 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New drug aims to heal hearts after attack – trial results awaited
Disease control CompletedThis study tested a new medicine called CDR132L in 294 people who had a recent heart attack and had weak heart pumping (ejection fraction 45% or less). Participants received one of two doses of CDR132L or a placebo, added to standard care, for 6 months. The goal was to see if the…
Phase: PHASE2 • Sponsor: Cardior Pharmaceuticals GmbH • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New breathing tech aims to free ICU patients from ventilators faster
Disease control CompletedThis study tested whether a newer breathing support method called NAVA helps patients with ARDS come off mechanical ventilation faster than standard PSV. 130 tracheotomy patients were randomly assigned to one of the two methods. The main goal was to see how many days patients wer…
Phase: NA • Sponsor: Southeast University, China • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Heart study tests Lower-Dose blood thinner and new stents for better safety
Disease control CompletedThis study looked at over 3,400 people with acute coronary syndrome (a heart attack or unstable angina) who received a stent to open blocked arteries. Researchers compared two types of stents (biostable vs. biodegradable polymer) and two doses of the blood thinner prasugrel (5 mg…
Phase: PHASE4 • Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New antibody drug aims to block brain attacks in autoimmune encephalitis
Disease control CompletedThis early-stage trial tested a new drug called ART5803 in 64 healthy adults to see if it is safe. ART5803 is a lab-made antibody designed to block harmful immune proteins that attack the brain in autoimmune encephalitis. The study gave single or multiple doses and compared them …
Phase: PHASE1 • Sponsor: Arialys Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New hope for young leukemia patients: combination chemo shows promise
Disease control CompletedThis study tested a combination of chemotherapy drugs in 318 adolescents and young adults (ages not specified but typically 15-39) with newly diagnosed acute lymphoblastic leukemia (ALL). The goal was to see how well the treatment worked at killing cancer cells and stopping the d…
Phase: PHASE2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New drug duo shows promise for rare blood cancer
Disease control CompletedThis completed phase 2 study tested a combination of two drugs, isatuximab and cemiplimab, in 37 adults with relapsed or refractory NK/T-cell lymphoma, a rare and aggressive blood cancer. The goal was to see if the combination could shrink tumors or stop the cancer from growing. …
Phase: PHASE2 • Sponsor: Won Seog Kim • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Potassium binder lets heart patients get full drug benefits
Disease control CompletedThis study tested whether a drug called Lokelma (SZC) can help people with both chronic kidney disease and heart failure safely reach higher doses of life-saving heart medications (RAAS inhibitors) without dangerous potassium spikes. 112 adults with stable kidney disease and hear…
Phase: PHASE3 • Sponsor: St George's, University of London • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Engineered immune cells show promise against tough childhood cancers
Disease control CompletedThis phase 1 trial tested a new therapy called CD22-CAR T cells in 134 children and young adults (ages 1-39) with B-cell leukemia or lymphoma that had not been cured by standard treatments. The therapy involves taking a patient's own white blood cells, modifying them in a lab to …
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Heart rehab from your couch? study tests Home-Based recovery
Disease control CompletedThis study looked at whether doing cardiac rehab at home, or a mix of home and clinic sessions, works as well as going to the clinic for all sessions. 206 heart patients participated, using a mobile health platform and home exercise. The goal was to see if flexible options could …
Phase: NA • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New study combines addiction treatment and IV antibiotics outside the hospital
Disease control CompletedThis study tested whether people with opioid use disorder and severe injection-related infections can be safely treated at home with antibiotics and buprenorphine (a medication for opioid use disorder). 71 participants were enrolled. The goal was to see if this integrated approac…
Phase: PHASE2 • Sponsor: Laura Fanucchi • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New combo aims to tame hairy cell leukemia with fewer side effects
Disease control CompletedThis study tested a combination of two drugs—vemurafenib (taken by mouth) and rituximab (given by IV)—in 15 people with hairy cell leukemia, a rare blood cancer. The goal was to see if this treatment works as well as or better than standard chemotherapy, but with fewer side effec…
Phase: PHASE2 • Sponsor: Scripps Health • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Supercharged immune cells take on relapsed leukemia in new trial
Disease control CompletedThis study tested a new approach for children and adults whose acute myeloid leukemia (AML) came back after a stem cell transplant. Researchers gave patients a special type of immune cell called cytokine-induced memory-like natural killer (CIML NK) cells, along with donor immune …
Phase: PHASE1, PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Cheap diabetes drug metformin slashes long COVID risk in major trial
Disease control CompletedThis study tested whether three common drugs—metformin, ivermectin, and fluvoxamine—could prevent severe illness and long COVID in 1,323 adults with early COVID-19. Participants were overweight or obese and not hospitalized. The key finding was that metformin reduced the risk of …
Phase: PHASE3 • Sponsor: University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New hope for kids with hard-to-treat leukemia: experimental combo shows promise
Disease control CompletedThis study tested a new combination of chemotherapy drugs for children and young adults with acute lymphoblastic leukemia (ALL) that had returned or not responded to first treatment. The goal was to find the safest dose of clofarabine when given with other medicines. Twenty parti…
Phase: PHASE1 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can CT scans guide better breathing support for ARDS patients?
Disease control CompletedThis study tested whether using lung CT images to guide ventilator settings could reduce deaths in people with ARDS. 420 adults were assigned to either standard ventilator care or a strategy based on their lung morphology. The goal was to see if personalized ventilation could imp…
Phase: NA • Sponsor: University Hospital, Clermont-Ferrand • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Promising drug combo targets tough leukemia in early trial
Disease control CompletedThis early-phase study tested a two-drug combination (pevonedistat plus decitabine) in 12 people with high-risk acute myeloid leukemia (AML), including those who had relapsed or couldn't tolerate standard chemo. The main goal was to find the safest dose and identify side effects.…
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can a common anesthetic gas help ARDS patients breathe easier?
Disease control CompletedThis study tested whether inhaling sevoflurane, a gas usually used for anesthesia, for the first 48 hours could improve oxygen levels and reduce inflammation in 50 adults with moderate to severe ARDS. Participants were randomly assigned to receive either sevoflurane or a standard…
Phase: PHASE4 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Could a cancer drug fix an irregular heartbeat?
Disease control CompletedThis study looked at whether Vidaza, a drug used for acute leukemia, could also help treat atrial fibrillation (an irregular heartbeat). The idea was that Vidaza might reverse certain DNA changes that lower the activity of a gene important for heart function. Only one person took…
Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can a lung drug stop transplant rejection? new trial tests Alpha-1 antitrypsin for GVHD
Disease control CompletedThis study tested whether a drug called alpha-1 antitrypsin (AAT) can prevent graft-versus-host disease (GVHD) in people receiving stem cell transplants for blood cancers. GVHD occurs when donor immune cells attack the patient's body. The trial enrolled 222 participants and compa…
Phase: PHASE2, PHASE3 • Sponsor: CSL Behring • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Could vitamin d help fight blood cancer?
Disease control CompletedThis study looked at whether giving vitamin D supplements to people with low vitamin D levels and newly diagnosed non-Hodgkin lymphoma or chronic lymphocytic leukemia could improve their outcomes. About 197 participants received either a low or high dose of vitamin D while underg…
Phase: NA • Sponsor: University of Nebraska • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can a common anesthetic help ARDS patients breathe easier?
Disease control CompletedThis study tested whether using sevoflurane (an inhaled anesthetic) for sedation could lower death rates and shorten time on a ventilator in patients with acute respiratory distress syndrome (ARDS). 700 adults were randomly assigned to receive either sevoflurane or standard propo…
Phase: PHASE3 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Experimental antibody IC14 tested in rare heart condition
Disease control CompletedThis early-phase trial tested IC14 (atibuclimab), an antibody that targets inflammation, in one person with arrhythmogenic cardiomyopathy (ACM), a rare heart muscle disease that can cause dangerous heart rhythms. The study measured safety, blood markers of inflammation, and heart…
Phase: PHASE1, PHASE2 • Sponsor: Implicit Bioscience • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Old drug, new hope: enasidenib may ease anemia in blood cancer patients
Disease control CompletedThis early-phase trial tested the drug enasidenib in 17 people with low-risk myelodysplastic syndrome or a related leukemia who had anemia and did not have a specific gene mutation. The goal was to see if the drug could safely improve red blood cell counts and reduce the need for…
Phase: PHASE1, PHASE2 • Sponsor: Tian Yi Zhang • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New drug combo tested for tough childhood leukemia
Disease control CompletedThis early-phase study tested whether adding the targeted drug palbociclib to standard chemotherapy is safe for children with acute lymphoblastic leukemia that has returned or not responded to treatment. Only 2 children took part, and the main goal was to find the highest tolerab…
Phase: PHASE1 • Sponsor: Tanja Andrea Gruber • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Blue dye may keep blood pressure up during kidney dialysis
Disease control CompletedThis study tested whether methylene blue, a dye that affects blood vessel function, can prevent dangerous drops in blood pressure during kidney dialysis. It involved 261 critically ill adults with acute kidney injury who needed dialysis. The goal was to see if the treatment could…
Phase: PHASE2 • Sponsor: Federal University of São Paulo • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New Two-Step transplant shows promise for blood cancer patients
Disease control CompletedThis study tested a two-step stem cell transplant for people with blood cancers like leukemia and lymphoma. First, patients received low-dose chemotherapy and radiation to prepare their bodies. Then, they got donor stem cells followed by drugs to prevent the donor cells from atta…
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New eyedrop shows promise for pink eye in small trial
Disease control CompletedThis study tested a new anti-infective eyedrop called SCH1 in 30 adults with acute infectious conjunctivitis (pink eye). Participants received either the active eyedrop or a placebo. The goal was to see if the drug could completely clear redness and discharge. The trial is comple…
Phase: PHASE2 • Sponsor: Sacsh • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Could adding calcium to ORS stop diarrhea faster?
Disease control CompletedThis study tested whether an oral rehydration solution (ORS) with added calcium works better than standard ORS for adults with severe watery diarrhea, including cholera. Researchers measured stool output, diarrhea duration, and other symptoms in 396 adults. The goal is to find a …
Phase: PHASE2, PHASE3 • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Common antibiotic could shield hearts after attack
Disease control CompletedThis study tested whether a short course of doxycycline, a common antibiotic, can prevent heart damage after a heart attack. 174 adults who had a severe heart attack received either doxycycline or a placebo twice daily for one week. Researchers then used MRI scans to check heart …
Phase: PHASE2 • Sponsor: University of Alberta • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New antibiotic cocktail takes on superbugs in phase 3 trial
Disease control CompletedThis study tested two new antibiotic combinations (cefepime/nacubactam and aztreonam/nacubactam) against the best available treatments for adults with serious infections like urinary tract infections, pneumonia, and abdominal infections caused by carbapenem-resistant bacteria. Th…
Phase: PHASE3 • Sponsor: Meiji Seika Pharma Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New drug shows promise in leukemia battle
Disease control CompletedThis study tested a new drug, crenolanib, against the standard drug midostaurin in adults with a specific genetic type of acute myeloid leukemia (FLT3-mutated AML). All 214 participants received standard chemotherapy and, if eligible, a bone marrow transplant, plus one of the two…
Phase: PHASE3 • Sponsor: Arog Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New drug combo aims to prevent leukemia return after remission
Disease control CompletedThis study tested whether a combination of two drugs, venetoclax and azacitidine, can help adults with acute myeloid leukemia (AML) stay in remission after initial chemotherapy. The goal was to find the right dose and see if it safely delays the cancer from coming back. The study…
Phase: PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Kidney transplant study: which drug better prevents rejection?
Disease control CompletedThis study tested two different drug combinations (Simulect or ATG, plus standard medications) in 60 kidney transplant patients at high risk of rejection. The goal was to see which approach better prevents treatment failure, including rejection, graft loss, or death, within 6 mon…
Phase: PHASE4 • Sponsor: University Hospital, Toulouse • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
One-Time artery fix may cut hospital time for heart attack patients
Disease control CompletedThis study looked at two ways to treat heart attack patients who have multiple blocked arteries. One group had all blockages fixed in a single procedure, while the other group had the main blockage fixed first and the others in a separate procedure later. The goal was to see if t…
Phase: NA • Sponsor: Tanta University • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New hope for elderly leukemia patients: drug combo shows promise
Disease control CompletedThis study tested a combination of two drugs, azacitidine and venetoclax, in 42 elderly patients (age 60+) with newly diagnosed acute myeloid leukemia (AML) who could not have standard chemotherapy. The treatment was given as an initial 'induction' phase, followed by a 'maintenan…
Phase: PHASE2 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Promising combo targets Leukemia's genetic weakness
Disease control CompletedThis study tested whether adding the drug crenolanib to standard chemotherapy helps adults up to age 75 with a hard-to-treat form of acute myeloid leukemia (AML) that has a specific genetic change (FLT3 mutation). Participants received either crenolanib or a placebo alongside che…
Phase: PHASE3 • Sponsor: Arog Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Engineered immune cells take on childhood leukemia and lymphoma in landmark trial
Disease control CompletedThis study tested a treatment called KTE-X19, a type of CAR T-cell therapy, in 95 children and adolescents whose B-cell acute lymphoblastic leukemia (ALL) or B-cell non-Hodgkin lymphoma (NHL) had returned or stopped responding to standard treatments. The therapy involves collecti…
Phase: PHASE1, PHASE2 • Sponsor: Kite, A Gilead Company • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New program boosts chemo compliance in children with leukemia
Disease control CompletedThis study tested a program to help children with acute lymphoblastic leukemia (ALL) take their daily chemotherapy medication (mercaptopurine) as prescribed during maintenance therapy. 570 children in remission were randomly assigned to either the intervention program or standard…
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Dietary change may curb recurrent c. diff in cancer patients
Disease control CompletedThis study tested whether eating less fat and more fiber can reduce the chance of a repeat Clostridioides difficile infection in cancer patients. Eight participants with leukemia, lymphoma, or other cancers followed a specific diet. Researchers tracked diarrhea and measured C. di…
Phase: NA • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Personalized plans boost survival odds for older stem cell patients
Disease control CompletedThis study tested a personalized geriatric optimization plan (GO!) in 30 adults aged 60 and older who were getting a donor stem cell transplant for blood cancers or bone marrow failure. The plan included tailored advice on diet, sleep, activity, and medications to improve physica…
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Pharmacists on the frontline: new study aims to cut opioid overdose deaths after prison
Disease control CompletedThis study tested whether a pharmacist-led program could help people leaving jail get treatment for opioid use disorder and prevent overdoses. Participants received overdose training, Narcan nasal spray, counseling, and referrals to medication treatment after release. The goal wa…
Phase: NA • Sponsor: University of Arkansas • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Can a Drug-Vaccine combo delay leukemia in High-Risk patients?
Disease control CompletedThis phase 2 trial tested whether giving the targeted drug ibrutinib along with standard vaccines (pneumonia, flu, and Tdap) can help people with early-stage, high-risk chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) stay progression-free longer. The study …
Phase: PHASE2 • Sponsor: Jennifer Woyach • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New cocktail aims to tackle tough myeloma cases
Disease control CompletedThis study tested a combination of thalidomide, bortezomib, and high-dose melphalan followed by a stem cell transplant in 29 patients with advanced multiple myeloma who had already failed one round of treatment. The goal was to find the safest dose of thalidomide and see how well…
Phase: PHASE1, PHASE2 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New targeted therapy shows promise for Tough-to-Treat leukemia
Disease control CompletedThis study tested a drug called GO-203-2C, which targets a protein (MUC1) found on cancer cells while sparing healthy cells. It was given alone or with another drug (decitabine) to 33 adults with acute myeloid leukemia that had returned or not responded to treatment. The main goa…
Phase: PHASE1, PHASE2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New drug combo shows promise in preventing transplant complications
Disease control CompletedThis early-stage study tested whether adding a drug called BMS-986004 to standard immune-suppressing medicine could help prevent acute graft-versus-host disease (GVHD) in 45 adults with blood cancers or disorders receiving a stem cell transplant. GVHD occurs when donor immune cel…
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Engineered immune cells take on tough blood cancers in early trial
Disease control CompletedThis study tested a new treatment called CTX131 for adults with certain blood cancers (T-cell lymphoma, B-cell lymphoma, or acute myeloid leukemia) that had returned or stopped responding to standard therapy. CTX131 uses a patient's own immune cells, modified with CRISPR gene edi…
Phase: PHASE1, PHASE2 • Sponsor: CRISPR Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New combo therapy may boost heart recovery after attack
Disease control CompletedThis study looked at 128 heart attack patients who had a procedure to open blocked arteries. Some patients received an extra blood thinner called cangrelor on top of standard ticagrelor. The goal was to see if the combination improved blood flow to the heart and reduced leftover …
Phase: PHASE4 • Sponsor: University Hospital, Caen • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New hope for HIV patients with rare brain disease?
Disease control CompletedThis study tested whether adding a powerful HIV drug called FUZEON® to standard antiretroviral therapy could help people with HIV who also have a rare brain infection called PML. PML is caused by a virus that attacks the brain when the immune system is weak. The goal was to see i…
Phase: PHASE2 • Sponsor: French National Agency for Research on AIDS and Viral Hepatitis • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New drug cocktail aims to tame deadly transplant complication
Disease control CompletedThis study tested whether adding pacritinib to standard immune-suppressing drugs (sirolimus and tacrolimus) could prevent graft-versus-host disease (GVHD) in 40 patients receiving stem cell transplants for blood cancers. GVHD occurs when donor immune cells attack the recipient's …
Phase: PHASE1, PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Stem cell hope for leukemia patients
Disease control CompletedThis study looked at whether a stem cell transplant can help people under 65 with untreated chronic lymphocytic leukemia (CLL) live longer without their cancer getting worse. 241 participants received either standard treatment or a transplant. The main goal was to see how long th…
Phase: PHASE3 • Sponsor: University Hospital, Caen • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New cocktail aims to wipe out CLL early
Disease control CompletedThis phase 2 trial tested a combination of chemotherapy (FCR) plus the drug lenalidomide in 21 people with previously untreated chronic lymphocytic leukemia (CLL). The goal was to see if adding lenalidomide could help more patients achieve a complete response, meaning no signs of…
Phase: PHASE2 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Could a simple gas help ventilated COVID-19 patients breathe easier?
Disease control CompletedThis study tested whether breathing in nitric oxide gas can improve oxygen levels in severely ill COVID-19 patients who are on ventilators. Researchers enrolled 200 adults in the ICU with confirmed COVID-19 and severe breathing problems. Patients received either standard care plu…
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New drug combo aims to tame deadly transplant complication
Disease control CompletedThis phase II trial tested whether adding the drug itacitinib to standard medications (tacrolimus and sirolimus) can better prevent graft-versus-host disease (GVHD) in 59 patients with blood cancers receiving donor stem cell transplants. GVHD occurs when donor immune cells attack…
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Engineered immune cells take aim at tough blood cancers
Disease control CompletedThis study tested whether a new type of immune cell therapy, called CD22 CAR T cells, could be made from patients' own blood cells and safely given to adults with hard-to-treat B-cell leukemia or lymphoma. The main goals were to see if the cells could be produced successfully and…
Phase: PHASE1 • Sponsor: Matthew Frank • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New drug shows promise for dangerous pancreatitis complication
Disease control CompletedThis study tested an experimental drug called CM4620-IE in 21 people with severe pancreatitis that caused body-wide inflammation (SIRS). The goal was to see if the drug is safe and to find the best dose for future studies. Participants received the drug plus standard care or stan…
Phase: PHASE2 • Sponsor: CalciMedica, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Steroid shot before angioplasty may limit heart damage
Disease control CompletedThis study tested whether giving a single, strong dose of steroids to people right after a major heart attack (STEMI) could reduce the amount of heart muscle that gets permanently damaged. The steroid was given before the standard emergency procedure to open the blocked artery. T…
Phase: PHASE2 • Sponsor: Thomas Engstrom • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Which sedative is safer for emergency intubation? large trial seeks answers
Disease control CompletedThis study compared two common sedatives, ketamine and etomidate, used when critically ill adults need a breathing tube placed in an emergency. About 2,367 patients took part to see which drug leads to fewer deaths and heart problems. The goal is to find the safer option for this…
Phase: PHASE4 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Expanded cord blood transplant shows early promise for young cancer patients
Disease control CompletedThis study tested a new method of cord blood transplantation in 13 children and young adults with high-risk myeloid cancers. The approach uses a molecule called UM171 to grow more stem cells from a single cord blood unit, aiming to speed up recovery and reduce complications. Earl…
Phase: PHASE1, PHASE2 • Sponsor: ExCellThera inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New radiation combo aims to boost stem cell transplant success in tough leukemia cases
Disease control CompletedThis study tested a new way to prepare patients with relapsed or hard-to-treat acute leukemia for a donor stem cell transplant. It combined a precise form of radiation therapy (IMRT) with two chemotherapy drugs (etoposide and cyclophosphamide) before the transplant. The goal was …
Phase: PHASE1, PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New pill combo aims to improve AML treatment in Non-FLT3 patients
Disease control CompletedThis phase 2 trial tested whether adding the targeted drug quizartinib to standard chemotherapy helps adults with newly diagnosed acute myeloid leukemia (AML) that does not have a FLT3 mutation. 273 patients were randomly assigned to receive either quizartinib or a placebo alongs…
Phase: PHASE2 • Sponsor: PETHEMA Foundation • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New radiation technique aims to make stem cell transplants safer for leukemia patients
Disease control CompletedThis study tested a new way to give radiation before a stem cell transplant for people aged 16 to 45 with acute lymphoblastic leukemia (ALL). The goal was to see if targeting radiation only to the bone marrow and lymph nodes (called TMLI) is safe and works as well as full-body ra…
Phase: NA • Sponsor: Hospital Universitario Dr. Jose E. Gonzalez • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Cord blood boost: new technique shows promise for tough leukemia cases
Disease control CompletedThis study tested a new way to prepare cord blood for transplant in 30 people with high-risk leukemia or myelodysplasia. The cord blood was treated with a molecule called UM171 to help it grow more stem cells. The goal was to see if this approach is safe and helps patients recove…
Phase: PHASE2 • Sponsor: ExCellThera inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Can kids with cancer stop antibiotics sooner? new trial investigates
Disease control CompletedThis study looked at whether children with cancer and a fever caused by low white blood cells can safely stop antibiotics earlier than usual. 55 children took part, and half stopped antibiotics once their fever was gone for 48 hours, while the other half continued until their whi…
Phase: PHASE4 • Sponsor: Murdoch Childrens Research Institute • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Could one drug replace two after a heart attack stent?
Disease control CompletedThis study looked at whether using only ticagrelor (a blood thinner) after heart attack stenting is safe, instead of the usual two-drug combination. It included 200 adults who had a stent placed during a heart attack. The main goal was to check for serious heart problems or stent…
Phase: PHASE2 • Sponsor: Vastra Gotaland Region • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
No-Surgery gallbladder fix shows promise in small trial
Disease control CompletedThis study tested a procedure called EUS-guided gallbladder drainage (EGBD) as an alternative to gallbladder removal surgery for 30 adults with acute cholecystitis (gallbladder inflammation). The goal was to see if it could safely resolve symptoms like fever and pain without need…
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New drug combo shows promise for untreated leukemia patients
Disease control CompletedThis study tested a combination of two drugs, idelalisib and ofatumumab, in 27 adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who had not received prior treatment. The goal was to see if the combo could shrink or control the cancer better than …
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New Two-Step transplant shows promise for tough blood cancers
Disease control CompletedThis phase 2 trial tested a two-step stem cell transplant approach for 47 patients with high-risk blood cancers like leukemia and lymphoma. The method uses the drug cyclophosphamide to lower the chance of graft-versus-host disease (GVHD), a common complication. The goal was to se…
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Could stem cells help COVID-19 patients breathe easier?
Disease control CompletedThis study tested whether a single dose of stem cells (mesenchymal stromal cells) could help patients with severe COVID-19 lung inflammation breathe better. Twenty adults with confirmed COVID-19 and acute respiratory distress syndrome were randomly assigned to receive either the …
Phase: PHASE2 • Sponsor: Cristina Avendaño Solá • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New breathing machine method aims to shield heart in lung failure patients
Disease control CompletedThis completed study tested a breathing machine strategy that uses lung pressure measurements to guide settings, aiming to protect the right side of the heart in patients with acute respiratory distress syndrome (ARDS). Forty adults on ventilators for less than 72 hours were incl…
Phase: NA • Sponsor: Beijing Chao Yang Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
AI beats the clock: new platform could speed up heart attack diagnosis
Diagnosis CompletedThis study tests an artificial intelligence platform called Willem that analyzes electrocardiograms (ECGs) to detect heart attacks. Researchers will compare how fast and accurately the AI spots heart attack patterns versus human doctors. The study involves 500 adults who have had…
Sponsor: Idoven 1903 S.L. • Aim: Diagnosis
Last updated Jul 04, 2026 00:00 UTC
-
New One-Hour blood test could speed up heart attack diagnosis
Diagnosis CompletedThis study tested a new one-hour diagnostic algorithm using a protein called FABP to quickly confirm or rule out a type of heart attack called NSTEMI. It involved 20 male patients who arrived at the hospital within 4 hours of chest pain. The goal was to see if measuring FABP leve…
Phase: NA • Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences • Aim: Diagnosis
Last updated Jun 28, 2026 00:00 UTC
-
Tiny camera inside the gut could spot transplant complication faster
Diagnosis CompletedThis pilot study tested a special microscope-like camera (endocytoscopy) to diagnose upper gut graft-versus-host disease (aGVHD) in 14 patients who had a stem cell transplant. The camera was used during a standard endoscopy to see cells in real time. The goal was to see if this t…
Sponsor: Ruijin Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 14:03 UTC
-
Urine test may predict kidney recovery in septic shock patients
Diagnosis CompletedThis study tested whether a urine test measuring two proteins (TIMP2 and IGFBP7) can tell which septic shock patients will recover normal kidney function within 72 hours. Researchers analyzed data from 77 patients in French ICUs. The goal is to help doctors decide who needs aggre…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Diagnosis
Last updated Jun 27, 2026 14:02 UTC
-
Ultrasound may reveal hidden causes of ventilator weaning failure
Diagnosis CompletedThis study explores whether ultrasound can identify the reasons some patients fail to come off a mechanical ventilator. Researchers will scan the heart, lungs, and diaphragm of adults who have been on a ventilator for at least 24 hours and have not passed a spontaneous breathing …
Sponsor: University Health Network, Toronto • Aim: Diagnosis
Last updated Jun 27, 2026 14:02 UTC
-
New urine test may spot kidney danger before it strikes
Diagnosis CompletedThis study tested a new urine test (RENISCHEM L-FABP) to see if it can predict acute kidney injury within 2 days after heart or blood vessel procedures that use contrast dye. Researchers measured a kidney stress marker in 382 adults at higher risk. The goal was to validate the te…
Sponsor: Hikari Dx, Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 13:08 UTC
-
New device may predict kidney recovery in ICU patients
Diagnosis CompletedThis study tested whether the Nephrocheck™ device can predict if early acute kidney injury will reverse within 72 hours in patients with septic shock. Researchers enrolled 184 adults in the ICU and measured the device's accuracy. The goal is to help doctors decide who might recov…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Diagnosis
Last updated Jun 27, 2026 13:06 UTC
-
AI-Powered Low-Radiation CT scans could transform emergency diagnosis
Diagnosis CompletedThis study tested whether a low-dose CT scan, enhanced with deep learning image reconstruction, can diagnose acute abdominal conditions as accurately as a standard CT scan. 246 adults with abdominal pain received both scans, and the low-dose version used less than 30% of the usua…
Sponsor: Oslo University Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 13:05 UTC
-
New PET tracer aims to spot hidden cancers without biopsy
Diagnosis CompletedThis completed early-phase study tested a new radioactive tracer called 18F-BL40 for PET/CT scans in 10 adults with certain blood cancers (like lymphoma and leukemia). The goal was to see if it safely and accurately detects tumors by targeting a receptor common in many cancers. R…
Sponsor: British Columbia Cancer Agency • Aim: Diagnosis
Last updated Jun 27, 2026 13:02 UTC
-
New scan may spot hidden heart infections
Diagnosis CompletedThis study tested whether a special PET-CT scan using a radioactive tracer (18F-FDG) can improve diagnosis of infectious endocarditis on natural heart valves. Researchers scanned 31 adults with suspected endocarditis within 5 days of starting care. The goal was to see how well th…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Diagnosis
Last updated Jun 27, 2026 13:01 UTC
-
Simple ultrasound test may spot kidney risk in preeclampsia patients
Diagnosis CompletedThis study tested whether a special ultrasound score (called VEXUS) can predict acute kidney injury in women with severe preeclampsia when they are admitted to the hospital. Researchers examined 70 women using Doppler ultrasound to check blood flow in key veins. The goal was to s…
Sponsor: Cairo University • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
New ultrasound could spot heart trouble before It's too late for chemo patients
Diagnosis CompletedThis study tested whether a special heart ultrasound (2D strain imaging) can detect early signs of heart damage caused by anthracycline chemotherapy in 100 leukemia patients. The goal is to catch problems sooner, so doctors can adjust treatment and reduce the risk of permanent he…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Diagnosis
Last updated Jun 27, 2026 12:39 UTC
-
Blood test may replace scans for heart attack staging
Diagnosis CompletedThis study looked at whether a high-sensitivity blood test for troponin I can accurately determine the stage of a heart attack. Researchers analyzed data from 312 patients across multiple hospitals. The goal is to provide a faster, simpler way to classify heart attack severity wi…
Sponsor: Rohan Dharmakumar • Aim: Diagnosis
Last updated Jun 27, 2026 12:35 UTC
-
Heart attack diagnosis gets a Sex-Specific upgrade: new study could save Women's lives
Diagnosis CompletedThis study looked at whether using different blood test cutoffs for men and women can better diagnose heart attacks. Current tests use the same cutoff for both sexes, which may miss heart attacks in women and over-diagnose them in men. Researchers tested new sex-specific cutoffs …
Phase: NA • Sponsor: Herlev Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:33 UTC
-
Light sensor may spot kidney danger during heart surgery
Diagnosis CompletedThis study looked at whether a special light-based monitor (near-infrared spectroscopy) placed on the skin can help predict kidney injury after heart surgery. Researchers measured oxygen levels in the kidneys of 113 adults during surgery and checked if low levels were linked to l…
Sponsor: SERAY TÜRKMEN • Aim: Diagnosis
Last updated Jun 27, 2026 12:31 UTC
-
Blood test may spot deadly transplant complication earlier
Diagnosis CompletedThis completed study looked at whether certain proteins in the blood (called biomarkers) can help predict acute graft-versus-host disease (aGVHD) in 500 patients who had a stem cell transplant for blood cancers. Researchers measured levels of REG3, ST2, IL-6, IL-8, and TNF R ever…
Sponsor: Chinese PLA General Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:28 UTC
-
Heart attack patients under 60 get genetic screening for hidden cholesterol disorder
Diagnosis CompletedThis study tested whether offering genetic screening to younger heart attack patients (under 60) can uncover hidden cases of Familial Hypercholesterolemia (FH), an inherited condition causing very high cholesterol. Researchers recruited 140 patients admitted with a heart attack a…
Phase: NA • Sponsor: University of British Columbia • Aim: Diagnosis
Last updated Jun 27, 2026 12:28 UTC
-
ER heart scan may catch attacks earlier
Diagnosis CompletedThis study tested whether a simple bedside heart ultrasound measurement, called the S' wave, can help emergency doctors quickly identify acute coronary syndrome (heart attack or unstable angina) in patients with chest pain. Researchers enrolled 66 adults who came to the ER with c…
Phase: NA • Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain • Aim: Diagnosis
Last updated Jun 27, 2026 12:24 UTC
-
New imaging agent could sharpen detection of blood cancers
Diagnosis CompletedThis early-phase study tested a new radioactive tracer called [18F]-Fludarabine for PET scans in 10 people with untreated chronic lymphocytic leukemia or diffuse large B-cell lymphoma. The goal was to see how the tracer spreads in the body and how well it highlights cancer cells.…
Phase: PHASE1 • Sponsor: University Hospital, Caen • Aim: Diagnosis
Last updated Jun 27, 2026 12:04 UTC
-
Hospital push could shield seniors from preventable diseases
Prevention CompletedThis trial evaluates whether a hospital-based remedial vaccination strategy can improve Tdap-IPV (tetanus, diphtheria, pertussis, polio) vaccination rates in adults aged 65 and older in the Sarthe region of France. Participants are randomly assigned to receive either the remedial…
Phase: NA • Sponsor: Centre Hospitalier le Mans • Aim: Prevention
Last updated Jul 03, 2026 00:00 UTC
-
New shot may shield transplant patients from deadly immune attack
Prevention CompletedThis study tested a drug called abatacept, given as a shot under the skin, to prevent a serious complication called graft-versus-host disease (GVHD) in 29 adults with blood cancers. Participants received a stem cell transplant from a half-matched donor. The goal was to see if aba…
Phase: PHASE1, PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Prevention
Last updated Jun 27, 2026 13:06 UTC
-
New antibiotic may replace standard infection prevention in blood cancer patients
Prevention CompletedThis study tested whether fosfomycin, an older antibiotic, works as well as ciprofloxacin for preventing serious infections in people with blood cancers like leukemia or those receiving a stem cell transplant. 177 adults from 11 Spanish hospitals took part. The main goal was to s…
Phase: PHASE3 • Sponsor: Fundación para la Investigación Biosanitaria del Principado de Asturias • Aim: Prevention
Last updated Jun 27, 2026 13:01 UTC
-
Could a neck device shield lungs after brain trauma?
Prevention CompletedThis pilot study tested a non-invasive device that stimulates the vagus nerve (nVNS) in patients hospitalized with mild-to-moderate traumatic brain injury. The goal was to see if adding nVNS to standard care could prevent severe lung inflammation and the need for a breathing mach…
Phase: NA • Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) • Aim: Prevention
Last updated Jun 27, 2026 13:00 UTC
-
Could a common blood pressure pill stop PTSD before it starts?
Prevention CompletedThis study tested whether prazosin, a drug normally used for high blood pressure, could prevent post-traumatic stress disorder (PTSD) in people who recently experienced a traumatic event like an accident or assault. Researchers gave the drug to 15 adults who showed signs of acute…
Phase: PHASE2 • Sponsor: Hospices Civils de Lyon • Aim: Prevention
Last updated Jun 27, 2026 12:37 UTC
-
Coffee for preemies? study tests caffeine to shield tiny kidneys
Prevention CompletedThis study tested whether giving caffeine early to preterm babies (born before 32 weeks) can prevent acute kidney injury. 236 newborns received either caffeine or standard supportive care within 24 hours of birth. Researchers tracked kidney injury, hospital stay length, and survi…
Phase: NA • Sponsor: Muhammad Aamir Latif • Aim: Prevention
Last updated Jun 27, 2026 12:37 UTC
-
Cheap combo may stop pancreatitis after ERCP
Prevention CompletedThis study tested whether giving rectal indomethacin (an anti-inflammatory drug) along with extra fluids before an ERCP procedure could prevent pancreatitis, a painful complication. The trial included 60 patients who needed ERCP. The goal was to see if this simple, low-cost appro…
Phase: PHASE3 • Sponsor: Hospital General de Chihuahua - Dr. Salvador Zubirán Anchondo • Aim: Prevention
Last updated Jun 27, 2026 12:36 UTC
-
Alcohol lock may stop deadly infections in ICU patients
Prevention CompletedThis study tested a 60% ethanol (alcohol) lock solution to prevent serious catheter infections in 1,460 ICU patients with acute kidney failure needing dialysis. The ethanol lock is placed inside the catheter to kill germs. The goal was to see if it reduces major catheter-related …
Phase: PHASE3 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Prevention
Last updated Jun 27, 2026 12:35 UTC
-
Text reminders help get young kids vaccinated on time
Prevention CompletedThis study tested whether sending text message reminders to parents could increase routine vaccination rates in children aged 0-2 years. Over 1,000 families in Brooklyn, New York, whose children were behind on vaccines received texts when shots were due or coming due. The goal wa…
Sponsor: NYU Langone Health • Aim: Prevention
Last updated Jun 27, 2026 12:33 UTC
-
New 'Star Homes' aim to slash childhood disease in tanzania
Prevention CompletedThis study tested whether specially built houses (Star Homes) could reduce malaria, respiratory infections, and diarrhea in children under 13 in rural Tanzania. Over 1,100 children lived either in a Star Home or a traditional mud house. The Star Homes have screened windows, solar…
Phase: NA • Sponsor: University of Oxford • Aim: Prevention
Last updated Jun 27, 2026 12:29 UTC
-
Heart valve drug shows promise in preventing brain and kidney damage
Prevention CompletedThis study tested a drug called conestat alfa in 141 people undergoing a minimally invasive heart valve replacement (TAVI) for severe aortic stenosis. The goal was to see if the drug could reduce the risk of small strokes and kidney damage that can happen after the procedure. Par…
Phase: PHASE2 • Sponsor: University Hospital, Basel, Switzerland • Aim: Prevention
Last updated Jun 27, 2026 12:23 UTC
-
New drug could shield preemie lungs from chronic disease
Prevention CompletedThis early-stage trial tested a new drug called rfhSP-D in 18 premature babies born before 30 weeks. The goal was to find the safest dose that might prevent chronic lung disease, a common complication in preemies. The drug was given along with standard care to babies on breathing…
Phase: PHASE1 • Sponsor: University College, London • Aim: Prevention
Last updated Jun 27, 2026 12:04 UTC
-
Can a simple pill prevent pancreatitis after ERCP? new study tests two drugs
Prevention CompletedThis study tested whether taking oral N-Acetyl cysteine before an ERCP procedure could prevent pancreatitis as well as the standard treatment, rectal diclofenac. Forty-six adults at risk for pancreatitis after ERCP received one of the two drugs. The goal was to see which drug bet…
Phase: PHASE1, PHASE2 • Sponsor: Tanta University • Aim: Prevention
Last updated Jun 27, 2026 11:03 UTC
-
New prosthetic grows with kids: no more frequent replacements?
Symptom relief CompletedThis study is testing a new type of prosthetic leg for children aged 3 to 18 that can be easily adjusted as they grow. The device is designed to be fitted in a single session and adjusted by the wearer. Researchers will measure comfort, socket pressure, walking speed, and quality…
Phase: NA • Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Could a Two-Session online therapy ease earthquake trauma?
Symptom relief CompletedThis trial tests whether a brief online group therapy called EMDR Flash can help adults who survived the 2023 Kahramanmaraş earthquakes in Türkiye. Participants receive two 60-90 minute group sessions via Zoom and are compared to a waitlist group. The study measures changes in PT…
Phase: NA • Sponsor: Istanbul Galata University • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Which exercise helps kids bounce back after leukemia? new study tests two approaches
Symptom relief CompletedThis study looked at 72 children aged 10-18 who finished chemotherapy for acute lymphoblastic leukemia. Researchers compared two types of aerobic exercise—one with a steady intensity and one that gradually increases—to see which better improves heart and lung fitness. All kids ex…
Phase: NA • Sponsor: Cairo University • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
Cartoon calm: animated film may ease Kids' surgery fears
Symptom relief CompletedThis trial investigates whether a double-reading animated film, watched by both children and their parents before surgery, can reduce anxiety in children aged 3 to 7. The film uses avatars to walk the child through their hospital journey, from room to operating room. Researchers …
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Stomach lying may cut breathing support needs in sick infants
Symptom relief CompletedThis study tested whether placing infants under 6 months with moderate to severe bronchiolitis on their stomachs (prone position) while on high-flow oxygen could reduce the need for more intensive breathing support. A total of 452 infants in critical care were randomly assigned t…
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
New breathing device for newborns tested against standard care
Symptom relief CompletedThis study tested two non-invasive breathing machines in 49 newborns (born at 33 weeks or later) with respiratory distress. One machine is the standard nasal CPAP, and the other is a newer device called nasal high frequency percussive ventilation. Researchers measured brain oxyge…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New study tests best way to position ARDS patients to avoid bedsores
Symptom relief CompletedThis study tested two ways of positioning patients with severe lung injury (ARDS) who are on ventilators and placed face-down (prone) to help breathing. The goal was to see if a 'swimmer' position—where the head is turned and one arm is bent—causes fewer severe pressure sores tha…
Phase: NA • Sponsor: University Hospital, Tours • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Simple oxygen trick may protect newborns during emergency intubation
Symptom relief CompletedThis study tested whether giving extra oxygen through a small tube in the nose during breathing tube placement can prevent dangerous drops in oxygen levels in newborns. About 110 infants in the NICU took part. The approach is simple and could make a common emergency procedure saf…
Phase: NA • Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Shock waves ease shoulder pain in new study
Symptom relief CompletedThis study tested a treatment called radial shock wave phonophoresis for people with shoulder impingement syndrome. 70 adults aged 25-40 with shoulder pain were split into two groups: one got shock wave therapy plus standard physical therapy, the other got shock waves alone. The …
Phase: NA • Sponsor: MTI University • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Can acupuncture with electricity boost stroke healing?
Symptom relief CompletedThis study looked at whether electroacupuncture (a type of acupuncture with mild electric pulses) can lower inflammation and help people recover after a stroke. 17 adults who had their first ischemic stroke took part. Researchers measured changes in symptoms and blood markers to …
Phase: NA • Sponsor: China Medical University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
Which breathing machine works best for lung fluid emergencies?
Symptom relief CompletedThis study compared two breathing devices—CPAP and bilevel ventilation—in people with severe fluid buildup in the lungs (pulmonary edema). The goal was to see which device improves breathing faster. Participants were adults in respiratory distress. The results could help doctors …
Phase: PHASE3 • Sponsor: University Hospital, Rouen • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
Outpatient gallbladder surgery: a satisfying option for some?
Symptom relief CompletedThis study looked at whether emergency gallbladder removal (laparoscopic cholecystectomy) can be performed as an outpatient procedure, meaning patients go home the same day. Researchers measured patient satisfaction using a simple scale. The study enrolled 25 adults with acute ch…
Phase: NA • Sponsor: Hospital General de Chihuahua - Dr. Salvador Zubirán Anchondo • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
Eye movement therapy eases PTSD symptoms in jordan study
Symptom relief CompletedThis study tested whether Eye Movement Desensitization and Reprocessing (EMDR) therapy can help adults with post-traumatic stress disorder (PTSD) in Jordan. 70 people with moderate to severe PTSD symptoms were randomly assigned to receive EMDR from a psychiatric nurse or to a wai…
Phase: NA • Sponsor: Al-Quds University • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Fencing fights fatigue: new program aims to keep blood cancer patients moving
Symptom relief CompletedThis study tested whether a fencing-based exercise program is practical for adults with leukemia or lymphoma who are receiving intensive treatment in a hospital. The goal was to reduce physical decline caused by long bed rest. Eighty patients were invited to take part, and resear…
Phase: NA • Sponsor: University Hospital, Angers • Aim: Symptom relief
Last updated Jun 27, 2026 12:39 UTC
-
Acupressure eases heart Patients' anxiety, study finds
Symptom relief CompletedThis study tested whether acupressure, a technique that applies pressure to specific points on the body, can reduce anxiety and improve vital signs like blood pressure and heart rate in people hospitalized with acute coronary syndrome (ACS). Sixty-eight adults with a first-time A…
Phase: NA • Sponsor: Abant Izzet Baysal University • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
New tool helps women with bladder infections skip unnecessary antibiotics
Symptom relief CompletedThis study tested whether a shared decision-making tool could help women with uncomplicated cystitis (bladder infection) and their doctors decide together about antibiotic use. 169 women aged 18-65 participated. The goal was to see if the tool reduced antibiotic use without harmi…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
New oxygen device may help breathing patients between treatments
Symptom relief CompletedThis study tested whether a high-flow oxygen system (Optiflow) works better than a standard oxygen mask for patients with breathing failure. About 100 adults in intensive care who needed non-invasive ventilation (NIV) took part. The goal was to see if Optiflow keeps oxygen levels…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
Can a common drug reverse Poison-Induced delirium? new study says yes
Symptom relief CompletedThis study tested whether rivastigmine can safely reverse delirium caused by poisoning from certain drugs like clozapine or tricyclic antidepressants. 100 patients at a poison center received rivastigmine, and doctors measured their consciousness and agitation levels. The goal wa…
Phase: PHASE4 • Sponsor: Alexandria University • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
Which tonsil surgery hurts less? new study compares three techniques
Symptom relief CompletedThis study compared three different tonsil surgery methods in 72 people with chronic tonsillitis. The goal was to see which technique causes less pain, bleeding, and faster healing. Researchers measured outcomes like surgery time, blood loss, and recovery to find the best approac…
Phase: NA • Sponsor: Kafrelsheikh University • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
Virtual walking lifts spirits for those who cannot walk
Symptom relief CompletedThis study tested a 'Digital Strolling' program where people with severe mobility impairment use a virtual reality headset to walk in a digital world. 24 participants either used the VR walking or watched walking videos for 10 days. The goal was to see if this approach could impr…
Phase: NA • Sponsor: The Hong Kong Polytechnic University • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Curcumin vs. hangover: small study tests natural remedy
Symptom relief CompletedThis study tested whether a curcumin supplement (NatureU Cheers Friends Curcumin) could reduce hangover symptoms in 12 healthy adult men. Participants took either the curcumin or a standard hangover product before drinking alcohol, then reported their hangover severity the next m…
Phase: NA • Sponsor: OmniSolutions Laboratory Holdings Limited • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Sedation may ease risky lung exam in breathless patients
Symptom relief CompletedThis study tested whether giving propofol sedation during a lung exam (bronchoscopy) under noninvasive ventilation helps patients with severe breathing failure stay more comfortable and maintain oxygen levels. Forty-six adults with acute respiratory failure needing a diagnostic l…
Phase: PHASE3 • Sponsor: University Hospital, Bordeaux • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
Physiotherapy after breathing tube removal may cut respiratory failure risk
Symptom relief CompletedThis study tested whether physiotherapy (special breathing exercises and early movement) could prevent acute respiratory failure within 7 days after a breathing tube is removed in ICU patients at high risk. 245 patients took part. The goal was to see if physiotherapy reduces the …
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
Trauma recovery showdown: therapy vs. pills for PTSD growth
Symptom relief CompletedThis study looked at whether a special therapy called EMDR or antidepressant medication (SSRIs) helps people with PTSD grow and recover after trauma. 130 adults with PTSD were randomly assigned to one of the two treatments. The main goal was to see which approach leads to more pe…
Phase: NA • Sponsor: Asad Ullah Jan • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Vibration or electrical stimulation: which better fights ICU muscle loss?
Symptom relief CompletedThis study tested two non-drug treatments—whole-body vibration and neuromuscular electrical stimulation—in 60 ICU patients with muscle weakness. Patients received one of the therapies twice daily for two weeks, alongside standard care. Researchers measured muscle strength and thi…
Phase: NA • Sponsor: Cairo University • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
EMDR vs. pills: which works better for PTSD?
Symptom relief CompletedThis completed study tested two common PTSD treatments head-to-head: EMDR therapy (a talking therapy with eye movements) and SSRI antidepressants. Sixty adults with PTSD were randomly assigned to one treatment for six weeks. Researchers measured how many people achieved symptom r…
Phase: NA • Sponsor: Asad Ullah Jan • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Face-Down therapy could save COVID patients who refuse ventilators
Symptom relief CompletedThis study looked at whether lying face down (prone positioning) helps hospitalized COVID-19 patients who have low oxygen levels but are not candidates for breathing machines. About 596 adults took part. The goal was to see if this simple position change could lower the chance of…
Phase: NA • Sponsor: University of Calgary • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Team sedation strategy may shorten ventilator time for kids
Symptom relief CompletedThis study tested a team-based approach to managing sedation in children with acute respiratory failure who need a breathing machine. The goal was to reduce the number of days on the ventilator. Over 2,400 children from multiple hospitals participated, comparing the team approach…
Phase: NA • Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
New dye formula could make emergency gallbladder surgery safer
Symptom relief CompletedThis study tested a personalized dose of a dye called indocyanine green (ICG) to help surgeons see bile ducts more clearly during emergency gallbladder removal. 21 patients with acute cholecystitis received a dye dose calculated from their MRI scans. The goal was to improve surgi…
Phase: NA • Sponsor: Peking Union Medical College Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Vibrating watch may disrupt PTSD nightmares, study finds
Symptom relief CompletedThis study tested a wearable device called NightWare that uses an Apple Watch to detect when a person is having a nightmare and gently vibrates to wake them just enough to stop the nightmare without fully waking them. The trial included 270 veterans and active-duty service member…
Phase: NA • Sponsor: NightWare • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
Magnetic pulses may ease Post-Polio symptoms
Symptom relief CompletedThis study tested whether adding transcranial magnetic stimulation (TMS) to standard exercise can reduce fatigue, pain, and improve walking in people with postpolio syndrome. 26 adults who had polio earlier in life and now have new symptoms took part. Half got TMS plus exercise, …
Phase: NA • Sponsor: Ege University • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
Online program eases belly pain in kids with pancreatitis
Symptom relief CompletedThis study tested a web-based program to help children aged 10-19 with chronic or recurring pancreatitis manage their abdominal pain. The program teaches cognitive behavioral skills to reduce pain and improve quality of life. 90 participants were enrolled, and the study measured …
Phase: NA • Sponsor: Seattle Children's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
Exercise and talk therapy show promise for PTSD relief
Symptom relief CompletedThis small study tested whether 8 sessions of brief exposure therapy combined with moderate exercise can reduce PTSD symptoms in adults. Twelve participants attended twice-weekly sessions for 4 weeks and completed questionnaires. The goal was to see if this treatment is acceptabl…
Phase: NA • Sponsor: Troy Hubert • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
Ear zap eases pancreatitis pain? new study says maybe.
Symptom relief CompletedThis study tested a non-invasive device that stimulates a nerve in the ear (taVNS) to see if it can calm inflammation and improve gut function in people with acute pancreatitis. Sixty adults with early-stage pancreatitis received either the real stimulation or a sham device. The …
Phase: NA • Sponsor: Air Force Military Medical University, China • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
Phone calls may boost chemo success in leukemia patients
Symptom relief CompletedThis study tested whether weekly nurse phone calls could help people with chronic lymphocytic leukemia (CLL) stick to their chemotherapy plan and reduce side effects. Sixty patients were split into two groups: one received regular care, and the other also got a weekly call to che…
Phase: NA • Sponsor: University Hospital, Toulouse • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
Could a blood pressure drug ease Veterans' Post-Concussion headaches?
Symptom relief CompletedThis study tested whether prazosin, a drug used for high blood pressure and PTSD nightmares, can reduce headaches in veterans and service members who had a mild traumatic brain injury. 89 participants received either prazosin or a placebo for 12 weeks. Researchers tracked headach…
Phase: PHASE1, PHASE2 • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
Warm IV fluid eases pain for emergency eye patients
Symptom relief CompletedThis study tested whether warming the intravenous (IV) mannitol fluid before giving it to people with sudden high eye pressure can reduce pain and improve comfort. 142 adults took part, with half getting warmed mannitol and half getting standard (room temperature) mannitol. The g…
Phase: NA • Sponsor: Joint Shantou International Eye Center of Shantou University and the Chinese University of Hong Kong • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Sleep band may help heart patients rest in noisy hospital units
Symptom relief CompletedThis study tested whether wearing an eye-ear sleep band, which blocks light and noise, could improve sleep quality in 100 adults admitted to a coronary care unit with acute coronary syndrome. Each patient spent one night with the band and one night with standard care, in random o…
Phase: NA • Sponsor: Koç University • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Mom's voice may soothe kids out of anesthesia delirium
Symptom relief CompletedThis study tested whether playing a recording of a mother's voice to children as they wake up from anesthesia can reduce postoperative delirium. Eighty children having tonsil surgery took part. Half heard their mother's reassuring voice during recovery; the other half did not. Re…
Sponsor: Enes Celik • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Heart-Smart chemo: new infusion method aims to protect AML patients
Symptom relief CompletedThis early-stage study looked at whether giving two standard chemotherapy drugs (cytarabine and daunorubicin) in a different way could be safer for the heart in adults newly diagnosed with acute myeloid leukemia (AML). Researchers used heart MRI scans to monitor for damage. The g…
Phase: PHASE1 • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
New breathing techniques tested on premature babies show promise
Symptom relief CompletedThis study looked at two different chest therapy methods—Vojta reflex and lung squeezing—to help premature babies (28-36 weeks) with breathing problems. 90 babies were split into three groups: one got standard care, the others got standard care plus one of the two extra technique…
Phase: NA • Sponsor: Beni-Suef University • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
Scientists probe why lung disease raises COVID-19 risk
Knowledge-focused CompletedThis study investigates how the immune system responds to COVID-19 in people with chronic lung conditions like asthma, COPD, or cystic fibrosis, compared to those without lung disease. Researchers collect blood, sputum, and nasal samples to measure immune signals and gene activit…
Sponsor: Imperial College London • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
PET scans may reveal hidden leukemia spots before CAR t treatment
Knowledge-focused CompletedThis pilot study tested whether PET-CT scans can detect leukemia that has spread outside the bone marrow in patients with relapsed or hard-to-treat B-cell acute lymphoblastic leukemia (ALL). Ten participants received a PET scan before and after CAR T-cell therapy. The goal was to…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Tape measure may spot hidden heart attack danger
Knowledge-focused CompletedThis study looks at whether the neck-to-waist ratio can help identify patients with high blood pressure and a specific type of heart attack. Researchers measured body shapes of 238 adults arriving at the emergency room with chest pain. The goal is to see if simple body measuremen…
Sponsor: Ercis Sehit Rıdvan Cevik State Hospital • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Ventilator showdown: which pressure setting saves lungs best?
Knowledge-focused CompletedThis study looks at 20 patients who have both high pressure in their belly (intra-abdominal hypertension) and severe lung injury (ARDS). Researchers will compare two methods for setting the ventilator's positive end-expiratory pressure (PEEP): one based on lung pressure measureme…
Phase: NA • Sponsor: XiaoJing Zou,MD • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Can genes predict liver damage from childhood cancer drugs?
Knowledge-focused CompletedThis study investigates whether certain genetic differences make children with nephroblastoma (kidney cancer) or acute lymphoblastic leukemia (blood cancer) more likely to develop a serious liver condition called hepatic veno-occlusive disease (VOD) during chemotherapy. Researche…
Phase: NA • Sponsor: University Hospital, Angers • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Contrast dye test reveals hidden kidney damage in ICU survivors
Knowledge-focused CompletedThis study uses a dye called iohexol to measure how well the kidneys are working in patients leaving the intensive care unit after acute kidney failure. The goal is to find out how many patients still have reduced kidney function even though their standard blood tests look normal…
Phase: PHASE3 • Sponsor: University Hospital, Angers • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Breathing test could shorten time on ventilators for lung failure patients
Knowledge-focused CompletedThis study tested a new breathing test to decide when to remove breathing tubes in patients with acute hypoxic respiratory failure. The test uses noninvasive ventilation to see if patients can breathe on their own earlier. Researchers hope this approach reduces time on invasive v…
Phase: NA • Sponsor: West China Hospital • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Ankle test may flag kidney danger after heart surgery
Knowledge-focused CompletedThis study looked at 516 patients who had surgery for a torn aorta (aortic dissection). Researchers checked if a high ankle-brachial index (a simple test of blood flow in the legs) before surgery was linked to kidney problems afterward. The goal was to see if this test could help…
Sponsor: Nanjing First Hospital, Nanjing Medical University • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Heart attack aftermath: which treatment causes less internal bleeding?
Knowledge-focused CompletedThis study examined bleeding inside the heart muscle (intramyocardial hemorrhage) in 60 patients who had a severe type of heart attack called STEMI. Researchers compared two treatment strategies: giving clot-busting drugs followed by a procedure to open the artery, versus going s…
Phase: NA • Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
Nose surgery blood pressure study aims to protect kidneys
Knowledge-focused CompletedThis study looked at 110 adults having nose surgery (septoplasty) to see if different blood pressure targets during surgery affect kidney injury. Patients were split into two groups: one with a lower blood pressure target (50-57 mmHg) and one with a higher target (58-65 mmHg). Ki…
Phase: NA • Sponsor: Fatih Sultan Mehmet Training and Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Breathing machine may harm diaphragm: new study investigates
Knowledge-focused CompletedThis study looks at how breathing machines (mechanical ventilators) might injure the diaphragm, the main muscle used for breathing. Researchers will monitor 50 ICU patients over their first 7 days on the ventilator, measuring diaphragm activity and function. The goal is to unders…
Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Researchers hunt for clues to predict deadly pancreas infection
Knowledge-focused CompletedThis study reviewed medical records of 148 adults admitted to the ICU with severe acute pancreatitis. The goal was to find risk factors for infected pancreatic necrosis, a serious complication that raises the risk of death. By identifying these factors, doctors hope to diagnose a…
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Stem cell transplant leaves many women with hidden gynecological issues
Knowledge-focused CompletedThis study looked at 51 women who had a stem cell transplant for acute leukemia as adults. Researchers wanted to find out how many had gynecological problems like early menopause, vaginal graft-versus-host disease, or cervical issues two years after transplant. They also checked …
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Could a pneumonia drug boost leukemia treatment? small trial explores safety and dosing
Knowledge-focused CompletedThis early-phase trial tested whether adding atovaquone (a drug usually used to prevent pneumonia) to standard chemotherapy is safe and reaches effective levels in the blood. It involved 26 children and young adults (ages 1 month to 21 years) newly diagnosed with acute myeloid le…
Phase: EARLY_PHASE1 • Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
New imaging technique may help ventilator settings for lung injury patients
Knowledge-focused CompletedThis study tested a non-invasive imaging method called electrical impedance tomography (EIT) to measure airway opening pressure in 6 adults with acute lung injury or ARDS. The goal was to see if EIT could detect where and when small airways open during a slow breath, which might …
Phase: NA • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Simple urine test may predict kidney recovery after acute failure
Knowledge-focused CompletedThis study looked at 287 patients with acute kidney injury caused by tubular necrosis. Researchers measured two substances in urine (PIIINP and NGAL) to see if they could predict whether kidney function would return or if chronic kidney disease would develop. The goal is to find …
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Researchers review CAR T-Cell results in kids with B-ALL
Knowledge-focused CompletedThis study looked back at the medical records of 57 children and young adults (under 25) who received CAR T-cell therapy for B-cell acute lymphoblastic leukemia (B-ALL). The goal was to understand how well the treatment worked and what side effects occurred, especially in those w…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Where is safer for dialysis catheters: ER or dialysis unit?
Knowledge-focused CompletedThis study looked at 398 adults who needed a temporary dialysis catheter, comparing those who got it in the emergency department versus those who got it in the dialysis unit. Researchers tracked infections and blood clots in the catheter for 10 days after placement. The goal is t…
Sponsor: Antalya Health Sciences University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
New model predicts oxygen therapy failure in just 30 minutes
Knowledge-focused CompletedThis study aimed to predict whether high-flow nasal oxygen therapy would fail within 30 minutes for patients with acute respiratory failure. Researchers used data from 164 participants, including a special imaging technique called electrical impedance tomography, to build a predi…
Sponsor: Ruijin Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Heart MRI may reveal hidden damage in young cancer survivors after sepsis
Knowledge-focused CompletedThis pilot study tested whether a heart MRI could be done safely and effectively in children with cancer who recently had sepsis. The goal was to see if the MRI could find hidden heart inflammation or weakness that standard tests might miss. Only 7 children took part, and the foc…
Phase: NA • Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Breath test may warn of kidney danger in ICU
Knowledge-focused CompletedThis study looked at 155 critically ill patients on ventilators to see if the difference between carbon dioxide in their breath and blood could predict acute kidney injury. Researchers measured this gap over the first 24 hours in the ICU. The goal was to find a simple, early warn…
Sponsor: Malatya Egitim Ve Arastirma Hastanesi • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Scientists probe hidden memory system that might survive brain damage
Knowledge-focused CompletedThis completed study looked at how people learn and remember associations, like names or where you met someone. Researchers compared healthy young and older adults with patients who have memory problems from Alzheimer's or semantic dementia. They used memory tests and brain scans…
Phase: NA • Sponsor: Rennes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Tiny tweaks in oxygen targets could help preterm babies breathe better
Knowledge-focused CompletedThis study looked at whether a narrower oxygen saturation target range helps an automated oxygen control system work better for very low birth weight infants on breathing support. Eleven babies were randomly assigned to either a 3% or a shifted 3% target range. The goal was to se…
Phase: NA • Sponsor: Czech Technical University in Prague • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New study examines artery complications in child liver transplants
Knowledge-focused CompletedThis study looked at 583 children who had liver transplants and later developed narrowing or blockage of the liver artery. Researchers wanted to find out how common these problems are and what treatments work best. The goal is to improve care and outcomes for future patients.
Sponsor: University Medical Center Groningen • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Could natural immune cells help fight leukemia drug resistance?
Knowledge-focused CompletedThis completed study from France examined whether a specific type of immune cell (innate CD8+ T cells) is linked to how quickly resistance mutations develop in patients with chronic myeloid leukemia or Philadelphia-positive acute lymphoblastic leukemia. Researchers analyzed blood…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Breathing therapy may improve lung function in ventilated kids
Knowledge-focused CompletedThis completed study looked at whether a breathing treatment called Intrapulmonary Percussive Ventilation (IPV) can improve lung stiffness (compliance) in critically ill children who are on breathing machines. Researchers measured lung function before and after one IPV session in…
Sponsor: Northwell Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
ICU antibiotics under scrutiny: new study targets hidden brain risks
Knowledge-focused CompletedThis study followed 400 intensive care patients receiving beta-lactam antibiotics to see how often these drugs cause brain-related side effects like confusion or agitation. Researchers measured antibiotic levels in the blood and checked patients' neurological status several times…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
ECMO studied in 761 severe COVID-19 patients: does it help?
Knowledge-focused CompletedThis study looked at whether ECMO, a machine that does the work of the heart and lungs, helps people with severe COVID-19 who have lung failure or heart failure. Researchers tracked 761 patients across France to see how many survived and how quickly they recovered. The goal was t…
Sponsor: Rennes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:08 UTC
-
Immune system clues may predict infections in ICU patients
Knowledge-focused CompletedThis completed study looked at 686 patients with acute respiratory distress syndrome (ARDS) to see how their immune status affects the risk of secondary infections like herpes or cytomegalovirus. Researchers measured immune cells and virus reactivation in blood and lung samples. …
Sponsor: Charite University, Berlin, Germany • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
ICU kidney danger: new study tracks who gets hurt
Knowledge-focused CompletedThis study looked at 174 adults in the intensive care unit (ICU) to find out how often acute kidney injury happens and what factors make it more likely. Researchers tracked patients who stayed in the ICU for at least 48 hours, excluding those with kidney problems at the start. Th…
Sponsor: Haseki Training and Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Liver failure treatment MARS: does it help avoid transplants?
Knowledge-focused CompletedThis study looked back at the medical records of 27 patients with alcoholic hepatitis or sudden liver failure who received a treatment called MARS (a type of dialysis that cleans the blood). The goal was to see if MARS helped them survive without needing a liver transplant. Resea…
Sponsor: Methodist Health System • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Blood test may forecast kidney comeback in dialysis emergencies
Knowledge-focused CompletedThis completed study looked at 170 adults who needed emergency hemodialysis for acute kidney injury. Researchers measured three blood markers (Activin A, Nostrin, and Angiopoetin-2) before dialysis to see if they could predict whether the kidneys would recover or if the patient w…
Phase: NA • Sponsor: Muğla Sıtkı Koçman University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Kidney risk after lung surgery: new clues from 150 patients
Knowledge-focused CompletedThis study reviewed the records of 150 adults who had surgery to clear blood clots from the lung arteries. Researchers wanted to see who developed kidney injury within two days after surgery and what factors raised that risk. They looked at things like how long the patient was on…
Sponsor: Ebru Girgin Dinc • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Heart attack may leave hidden marks on the brain
Knowledge-focused CompletedThis study looked at 49 adults aged 30-65 who had a first heart attack about 4 months earlier. Researchers used brain scans to see if changes in the brain's blood vessels or structure are linked to memory or thinking problems. The goal is to better understand these issues and hel…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Gene test spots hidden leukemia in kids
Knowledge-focused CompletedThis study looked at 148 children with T-cell acute lymphoblastic leukemia to see if a high-tech gene test could find tiny amounts of cancer left after treatment. Researchers used next-generation sequencing to check for specific gene changes in immune cells. They then compared th…
Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
New nalmefene study could speed up opioid overdose rescue
Knowledge-focused CompletedThis study tested how a new form of nalmefene (a drug that reverses opioid overdoses) behaves in the body when given as a shot or through an IV. 13 healthy adults received single doses of both the new and standard versions. The goal was to see how quickly the drug reaches the blo…
Phase: PHASE1 • Sponsor: Knoa Pharma LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Hidden kidney risk during nose surgery? new study investigates
Knowledge-focused CompletedThis study looked at whether intentionally lowering blood pressure during nose surgeries (like rhinoplasty) might cause hidden kidney injury. Researchers measured two sensitive kidney biomarkers (NGAL and cystatin C) in 35 adults before and after surgery. The goal was to detect e…
Sponsor: Gazi University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
Breathing treatment showdown: no clear winner in lung opening study
Knowledge-focused CompletedThis study looked at two breathing treatments—high-flow oxygen and non-invasive ventilation—in 16 adults with sudden breathing failure from pneumonia. The goal was to see which one better opens up the lungs. The results showed no major difference in lung opening, though non-invas…
Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
Women's cycle phase linked to mountain sickness risk
Knowledge-focused CompletedThis study looked at whether the phase of a woman's menstrual cycle affects her chances of getting acute mountain sickness (AMS) when traveling to high altitude. Researchers followed 91 healthy women as they spent two days at 3600 meters (about 11,800 feet). The goal was to see i…
Sponsor: University of Zurich • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
Late heart attack intervention: helpful or not?
Knowledge-focused CompletedThis study looked at 150 patients who had a heart attack 12 to 36 hours earlier. Researchers wanted to see if opening the blocked artery right away was better than waiting a few days. They used MRI scans to measure heart muscle damage and function.
Phase: NA • Sponsor: Thomas Engstrom • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Kidney check: do current AKI tests really work in the ICU?
Knowledge-focused CompletedThis study looked at 1416 very sick adults in the ICU to see how well different stages of acute kidney injury (AKI) match the kidneys' actual ability to filter waste. Researchers used a urine test to measure kidney function and compared two common ways to diagnose AKI: one based …
Sponsor: University Hospital, Ghent • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Heart ultrasound may predict defibrillator need after heart attack
Knowledge-focused CompletedThis study tested whether a special heart ultrasound (speckle tracking echocardiography) can predict which patients need an implantable defibrillator (ICD) after a large heart attack. Researchers followed 200 patients for 90 days to see whose heart function stayed low enough to q…
Sponsor: Aswan University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Study aims to Fine-Tune oxygen delivery for sick infants
Knowledge-focused CompletedThis study measured the peak tidal inspiratory flow (PTIF)—how fast infants breathe in—in 50 babies under 6 months old with moderate to severe viral bronchiolitis. Researchers used a spirometer to record 20 breaths per infant within 24 hours of hospital admission. The goal was to…
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Scientists hunt for clues to kidney damage in sepsis
Knowledge-focused CompletedThis completed study looked at 211 people with sepsis, some of whom also had acute kidney injury. Researchers measured specific microRNAs and other markers in the blood to understand how kidney damage happens. The goal was to find new targets for diagnosis or treatment, not to te…
Sponsor: University Hospital Ostrava • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Heart attack stents face off: which heals better?
Knowledge-focused CompletedThis study looked at how well two types of stents (small mesh tubes) placed in heart arteries after a heart attack become covered by the body's own cells. 22 people who had a heart attack were randomly assigned to get either a SYNERGY stent or a bioresorbable scaffold. Doctors us…
Phase: NA • Sponsor: University Hospital, Toulouse • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Can your genes predict blood thinner success? new study targets caribbean hispanics
Knowledge-focused CompletedThis study looked at 150 Caribbean Hispanic adults with heart disease or stroke risk who take the blood thinner clopidogrel. Researchers wanted to see if certain gene variants affect how well the drug works. The goal is to understand why some people get less benefit and to pave t…
Phase: EARLY_PHASE1 • Sponsor: University of Puerto Rico • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Tapping away trauma? brain study hints EMDR technique may calm emotional reactivity
Knowledge-focused CompletedThis study tested whether a single 15-minute session of Butterfly Tapping, a self-administered EMDR technique, could change brain activity in 46 young adults with PTSD. Participants either did the tapping or sat still while their brain waves were recorded. The tapping group showe…
Phase: NA • Sponsor: University of Rome Foro Italico • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
New study tracks immune cell function after stem cell transplants to personalize care
Knowledge-focused CompletedThis completed study looked at how immune cells recover in 61 adults who received a stem cell transplant for blood cancers. Researchers measured the function of T and NK cells by testing their cytokine profiles after stimulation. The goal was to see if these measurements could he…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
Can a gut feeling save lives? ICU study tests simple predictions
Knowledge-focused CompletedThis study looked at 800 emergency ICU patients to see if simple checks and gut feelings from nurses and students can predict who will survive, just as well as complex scoring systems. The goal was to collect data and compare different prediction methods to find the easiest and m…
Sponsor: University Medical Center Groningen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
Which breathing support works best after extubation? small study investigates
Knowledge-focused CompletedThis study looked at 13 adults who had been on a breathing tube for at least 2 days and were at risk for breathing trouble after the tube was removed. Researchers compared two types of noninvasive breathing support: one that senses the patient's own breathing signals (NAVA) and o…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Tiny sleep study hopes to unlock breathing problems in COVID ICU survivors
Knowledge-focused CompletedThis study looked at whether neck muscle activity during sleep affects breathing recovery in 17 COVID-19 patients who were on ventilators in the ICU. Researchers used sleep tests and activity monitors to track sleep quality and breathing patterns. The goal was to understand why s…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Are cirrhosis patients getting the shots they need? french study finds out
Knowledge-focused CompletedThis study looked at how many people with cirrhosis in French general hospitals were vaccinated against diseases like hepatitis, flu, and COVID-19. Researchers surveyed 742 patients to see if they were up to date on their shots. The goal was to find gaps in vaccination coverage s…
Sponsor: Centre Hospitalier Sud Francilien • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Heart scan may forecast ICU stay for babies with severe bronchiolitis
Knowledge-focused CompletedThis study looked at 46 infants under 2 years old in the pediatric ICU with severe bronchiolitis. Researchers used a heart ultrasound measure called TAPSE to see if it could predict how long babies needed intensive care. The goal was to find a simple test that helps doctors plan …
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Can a simple sensor predict who needs a breathing tube?
Knowledge-focused CompletedThis pilot study tested a new algorithm that estimates how hard patients are working to breathe while on high-flow nasal oxygen. Researchers enrolled 20 ICU patients and used a noninvasive sensor to collect pressure and flow data. The goal was to see if the algorithm could reliab…
Phase: NA • Sponsor: Poitiers University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Can a smartphone app save more newborns? large study tests real-time feedback for resuscitation
Knowledge-focused CompletedThis study tested whether a mobile health app called LIVEBORN can help nurse midwives improve how they support newborns who have trouble breathing right after birth. Over 14,000 newborns and their nurses took part. The app gave either real-time guidance or a summary after the eve…
Phase: NA • Sponsor: University of North Carolina, Chapel Hill • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Small study checks kidney and race impact on transplant drug
Knowledge-focused CompletedThis study looked at how kidney function and race/ethnicity affect the drug treosulfan in 20 patients with AML or MDS getting a stem cell transplant. The goal was to find safe doses for those with kidney problems. It was a small, early-phase study that did not test a new treatmen…
Phase: PHASE1 • Sponsor: medac GmbH • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Scientists map hidden germs in kids with cancer
Knowledge-focused CompletedThis study looked at the tiny organisms (bacteria and fungi) living in the mouth and nose of children with leukemia or those getting a bone marrow transplant. Researchers wanted to see how these germ communities change during chemotherapy. The goal was to learn more, not to test …
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Stomach slowdown may delay heart attack drug action
Knowledge-focused CompletedThis completed study looked at whether stomach emptying is slower during a heart attack, which could delay the absorption of crucial antiplatelet drugs. Researchers measured paracetamol levels in the blood every 15 minutes in 23 participants to track stomach emptying. The goal wa…
Phase: PHASE4 • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Heart attack study reveals why every minute counts
Knowledge-focused CompletedThis study tracked 555 adults hospitalized with acute coronary syndrome (a serious heart condition) to see how quickly they called for help and what factors influenced their recovery. Researchers focused on delays in calling an ambulance and how those delays affected short- and l…
Sponsor: National Medical Research Center for Therapy and Preventive Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Can a simple ultrasound test predict who needs fluids in the ICU?
Knowledge-focused CompletedThis study looked at 50 ICU patients with acute respiratory failure to see if a heart ultrasound test (measuring how the main vein collapses) could predict who would die or need a breathing tube. The goal is to help doctors give fluids more safely. It was an observational study, …
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Blood cancer enzyme deficiency explored in new study
Knowledge-focused CompletedThis study looked at how often people with certain blood cancers or related conditions have an acquired deficiency of an enzyme called pyruvate kinase, which can cause anemia. Researchers took a single blood sample from 18 participants to measure enzyme activity and check for rel…
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Antibiotics before kidney drainage: help or hype?
Knowledge-focused CompletedThis study looked at whether giving antibiotics before a kidney drainage procedure (called percutaneous nephrostomy) prevents urinary tract infections in cancer patients whose urinary tract is blocked by a tumor. Researchers reviewed records of 320 cancer patients who had the pro…
Sponsor: Barretos Cancer Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Ultrasound may predict when tiny lungs can breathe on their own
Knowledge-focused CompletedThis study looked at whether a lung ultrasound score can help doctors decide when to safely remove a breathing tube from newborn babies with breathing problems. 71 infants in the NICU had an ultrasound before and after their breathing tube was removed. The goal was to see if the …
Phase: NA • Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
AI breathes new life into pediatric ICU ventilator care
Knowledge-focused CompletedThis completed study tested whether an AI system could improve how ventilators are set for children (ages 1 month to 18 years) in the pediatric ICU with breathing problems like pneumonia or respiratory failure. Researchers compared AI-generated recommendations to the actual adjus…
Sponsor: Wu Rongzhou • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
New 10-Question test could spot PTSD in car crash survivors
Knowledge-focused CompletedThis study tested a 10-item questionnaire called DEPITAC, designed for nurses to screen road traffic accident patients for post-traumatic stress disorder (PTSD) while they are still in the surgical unit. Researchers enrolled 274 hospitalized accident victims to see if the simple …
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
New ultrasound technique aims to better measure liver health
Knowledge-focused CompletedThis study tested a new ultrasound technique called ARFI to measure liver stiffness in 109 people, including healthy volunteers and patients with liver conditions. The goal was to understand normal stiffness values and how they change with disease or treatment. This is an observa…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
Mold infection risk in kids with leukemia: a 14-year review
Knowledge-focused CompletedThis study looked back at 621 children in Denmark who had chemotherapy for acute leukemia between 2008 and 2022. The goal was to find out how many got serious mold infections and what factors made it more likely. The results will help doctors better protect children during treatm…
Sponsor: University of Southern Denmark • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
New breathing tube technique shows promise for kids in surgery
Knowledge-focused CompletedThis study looked at a different way to help children breathe during surgery. Instead of placing the breathing tube all the way into the windpipe, doctors placed it just above the vocal cords. The goal was to see if this method is easy, safe, and works well. The study included 85…
Sponsor: American University of Beirut Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
New tool helps older leukemia patients and doctors talk better
Knowledge-focused CompletedThis study tested a tool called UR-GOAL to help older patients with acute myeloid leukemia (AML), their caregivers, and their doctors communicate better and make decisions together. It involved 161 participants aged 60 and older. The goal was to see if the tool improved shared de…
Phase: NA • Sponsor: University of Rochester • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Heart surgery study questions routine use of ultrasound probe
Knowledge-focused CompletedThis study looked at whether using a heart ultrasound probe (TEE) during low-risk coronary artery bypass surgery should be done routinely or only when needed. Researchers enrolled 40 patients and checked if it was possible to randomly assign them to one of two groups. The goal is…
Phase: NA • Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Premature baby breathing study completed: what works best?
Knowledge-focused CompletedThis study looked at 136 premature babies who needed breathing help. Researchers tracked how long they needed support and checked for lung problems. The goal was to learn more about different non-invasive breathing methods, not to test a new treatment.
Phase: NA • Sponsor: Universitair Ziekenhuis Brussel • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
New surgical clip tool tested in 161 patients
Knowledge-focused CompletedThis study looked at a new device called AE05ML that helps surgeons place clips on blood vessels and other tissues during keyhole surgery. The goal was to see if the device is safe and works well. A total of 161 adults took part in the study.
Sponsor: Teleflex • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Blood marker may flag surgery danger for seniors
Knowledge-focused CompletedThis study looked at nearly 30,000 older adults (65+) having non-cardiac surgery to see if levels of homocysteine, a natural amino acid, could predict serious complications like kidney injury or death. Researchers measured homocysteine before and after surgery. The goal was to se…
Sponsor: Chinese PLA General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Can better sleep help kids in the ICU recover faster?
Knowledge-focused CompletedThis study looked at ways to improve the care, environment, and daily routines of children in the pediatric intensive care unit (PICU) to support their healing and natural sleep-wake cycles. Researchers observed 56 children aged 6 months to 18 years who were on breathing machines…
Phase: NA • Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
New training aims to help doctors catch child abuse earlier
Knowledge-focused CompletedThis study looked at whether a new educational program helps doctors-in-training better recognize and respond to child maltreatment. 84 medical residents from Canadian universities took part. The program was delivered either in a group with a leader or on their own. The goal was …
Phase: NA • Sponsor: McMaster University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Ultrasound could help doctors manage fluids during kidney treatment
Knowledge-focused CompletedThis study looked at 100 critically ill adults with severe kidney failure who were receiving continuous kidney replacement therapy. Researchers used a special ultrasound technique to check for fluid buildup in the body, which can harm organs. The goal was to see how common fluid …
Sponsor: Chulalongkorn University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Could a simple gas reduce lung damage in ventilator patients?
Knowledge-focused CompletedThis study tested whether giving a gas sedative (isoflurane) instead of standard IV drugs could reduce the energy delivered to the lungs by the breathing machine in 40 ICU patients. The goal was to see if this approach might lower the risk of lung injury. The trial was small and …
Phase: NA • Sponsor: Mahidol University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
IPad brain games tested in young cancer survivors
Knowledge-focused CompletedThis study looked at whether children and teens who had a stem cell transplant for leukemia could use an iPad-based brain-training program. The main goal was to see if the program was practical and if kids would stick with it. Only 17 participants were enrolled, and the study foc…
Phase: NA • Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
New study aims to protect hearts of ARDS patients on ventilators
Knowledge-focused CompletedThis study looked at 10 adults with moderate-to-severe ARDS who were on breathing machines. Researchers used a non-invasive imaging method (EIT) to adjust ventilator pressure settings and then checked how the heart's right side responded using ultrasound. The goal was to find the…
Phase: NA • Sponsor: University of Padova • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Tiny pressure difference could save lungs on ventilators
Knowledge-focused CompletedThis study looked at 500 adults on breathing machines to see if measuring airway pressure at a specific moment (P1) versus a later moment (P2) better predicts lung damage. The goal is to find which measurement helps doctors set safer ventilator settings. No new treatment was test…
Sponsor: University of Padova • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Blood test may predict heart attack Patients' future risk
Knowledge-focused CompletedThis study looked at whether certain cells and substances in the blood can help predict if a person who has had a heart attack or unstable angina will have another heart problem within a year. Researchers took blood samples from 180 patients and tracked their health for one year.…
Phase: NA • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Face-Down breathing: new study tests simple position change for COVID-19 lung failure
Knowledge-focused CompletedThis study looked at whether lying face down (prone position) while awake can improve how air moves through the lungs in COVID-19 patients with breathing failure. Twenty adults with COVID-19 and low oxygen levels were monitored using a special imaging technique (EIT) to measure l…
Phase: NA • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
New biomarkers may spot kidney trouble after heart surgery
Knowledge-focused CompletedThis completed study looked at over 3,000 heart surgery patients who developed acute kidney injury. Researchers tested new biomarkers to see if they could predict which patients would get worse. The goal is to help doctors identify high-risk patients earlier and improve care.
Sponsor: Guowei Tu • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Ultrasound may spot preterm babies needing lung treatment earlier
Knowledge-focused CompletedThis study looked at whether chest ultrasound can predict which premature babies (born before 34 weeks) will need surfactant—a substance that helps their immature lungs work better. Doctors currently decide based on oxygen levels, which can delay treatment. Researchers performed …
Sponsor: South Tees Hospitals NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
COVID ICU survivors: does lying on your belly help years later?
Knowledge-focused CompletedThis study checks on 137 COVID-19 patients who were in the ICU and used awake prone positioning (lying on their belly) while on high-flow oxygen. Researchers want to see if this technique affects quality of life and survival more than two years later. Participants answer a phone …
Sponsor: University Hospital, Tours • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Leukemia Patients' hidden threat: fungal infections under microscope
Knowledge-focused CompletedThis study observed 150 adults with a specific type of leukemia (Ph-negative ALL) to see how many developed serious fungal infections during their first weeks of chemotherapy. Researchers tracked infection rates and deaths linked to these infections. The goal was to better unders…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Heart scan may predict recovery after heart attack
Knowledge-focused CompletedThis study looked at 30 people who had a heart attack and were treated with a procedure to open blocked arteries. Researchers used a special heart scan soon after treatment to see how much heart muscle was saved. They then checked if that scan could predict how well the heart wou…
Sponsor: Fayoum University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Blood clot markers may predict severe pancreatitis
Knowledge-focused CompletedThis completed study looked at 141 people with acute pancreatitis to understand how blood clotting changes during the illness. Researchers took blood samples over several days and will analyze them for markers that might predict whether the disease becomes mild, moderate, or seve…
Sponsor: Region Skane • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Running and swimming may temporarily stress kidneys, study finds
Knowledge-focused CompletedThis study looked at how a 10 km run and a 1.5 km swim affect kidney function in 40 healthy, active adults. Researchers used sensitive urine tests to detect subtle kidney changes that standard blood tests might miss. The goal was to better understand temporary kidney stress from …
Phase: NA • Sponsor: Hospital Clínico Universitario de Valladolid • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:26 UTC
-
New drug EP395 tested in humans for first time
Knowledge-focused CompletedThis early-stage study tested the safety and tolerability of a new drug called EP395 in 78 healthy adults aged 18-65. Participants received either EP395 or a placebo capsule, and researchers monitored side effects, vital signs, and hearing. The goal was to find a safe dose range …
Phase: PHASE1 • Sponsor: EpiEndo Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
Massive study reveals Real-World impact of respiratory failure in china
Knowledge-focused CompletedThis study observed over 4,000 patients in Chinese ICUs who needed breathing support for acute respiratory failure. Researchers tracked treatments, outcomes, and costs to better understand the disease burden. The goal is to improve care and identify risk factors, not to test a ne…
Sponsor: Southeast University, China • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
Real-World data on CPAP for COVID-19 respiratory failure
Knowledge-focused CompletedThis study looked at how well CPAP therapy works for COVID-19 patients who have trouble breathing. Researchers collected data from 250 patients in a hospital to see how they responded to treatment. The goal was to learn more about managing severe COVID-19 in real-life settings.
Sponsor: University of Milan • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
New study maps antibiotic resistance in bile duct infections to guide smarter treatment
Knowledge-focused CompletedThis study looked at 1435 patients with acute cholangitis (a bile duct infection) who had an ERCP procedure. Researchers analyzed bile samples to understand which bacteria were causing the infections and how resistant they were to antibiotics. The goal was to find patterns that c…
Sponsor: Emergency County Hospital Pius Brinzeu; Timisoara, Romania • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Healthy volunteers help test new drug for brain inflammation
Knowledge-focused CompletedThis early-stage study tested a single dose of a new drug called ART5803 in 7 healthy adults to see if it is safe and how it interacts with another medicine (IVIG). The goal was to gather information for future research on autoimmune encephalitis, a condition where the immune sys…
Phase: PHASE1 • Sponsor: Arialys Therapeutics • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
New nasal cannula design may ease breathing in respiratory failure
Knowledge-focused CompletedThis study tested whether an asymmetrical high-flow nasal cannula reduces the work of breathing compared to a conventional one in 40 patients with acute respiratory failure. Participants received both devices at different flow rates, and researchers measured diaphragm and chest m…
Phase: NA • Sponsor: Siriraj Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Which IV fluid spares kidneys best during back surgery in seniors?
Knowledge-focused CompletedThis study looked at 174 older adults (ages 65-80) having lumbar fusion surgery to see whether using sodium acetate Ringer's solution or sodium lactate Ringer's solution during the operation better protects the kidneys. Researchers measured early kidney injury markers in urine an…
Phase: NA • Sponsor: Xianping Wu • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
One year later: how Kids' lungs heal after ARDS
Knowledge-focused CompletedThis study followed 38 children who survived acute respiratory distress syndrome (ARDS), a severe lung condition. One year after leaving the hospital, researchers checked for lasting breathing problems like cough, wheeze, and lung stiffness using scans and tests. The goal was to …
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New imaging tool could help doctors set ventilators for lung injury patients
Knowledge-focused CompletedThis study tested whether a special imaging method called electrical impedance tomography (EIT) can help doctors choose the best ventilator settings for patients with severe lung injury (ARDS). The goal was to see if EIT could identify which patients would benefit from higher or …
Sponsor: Ruijin Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Heart attack recovery: do women and men get equal prevention care?
Knowledge-focused CompletedThis completed study looked at 530 heart attack survivors from 25 Spanish hospitals to see if women and men differ in how well they follow prevention advice, like taking medications, eating healthy, exercising, and joining rehab programs. Researchers matched women and men by age …
Sponsor: Spanish Society of Cardiology • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Can VR keep kids active and engaged after school? new study explores
Knowledge-focused CompletedThis study tested a virtual reality (VR) afterschool program for 32 children ages 9-17. The goal was to see if kids would use and enjoy the VR system, and to measure their physical activity. This was a pilot study to gather information, not to treat or cure any disease.
Phase: NA • Sponsor: University of Georgia • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Scientists hunt for hidden signs in blood cancers to personalize treatment
Knowledge-focused CompletedThis study collected blood, bone marrow, skin, and cheek cell samples from 650 adults with acute leukemia, myelodysplastic syndromes, or myeloproliferative disorders. Researchers analyzed the samples to find genetic, epigenetic, and drug sensitivity patterns that might predict ho…
Phase: NA • Sponsor: Institut Paoli-Calmettes • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Scientists collect kidney samples from COVID-19 patients to uncover clues about organ damage
Knowledge-focused CompletedThis completed study collected blood, urine, and kidney tissue from 90 COVID-19 patients with acute kidney injury. Researchers aimed to build a biorepository and analyze samples to better understand how COVID-19 affects the kidneys. The goal is to speed up discoveries and improve…
Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Eye infection study: does early surgery save sight better than drugs?
Knowledge-focused CompletedThis study looked back at 170 adults with a serious eye infection called endophthalmitis to see if early surgery (within 48 hours) helps vision more than starting with medicine alone. Researchers compared how well people could see one month after treatment. The goal is to find ou…
Sponsor: University Hospital, Brest • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Gut check: could your microbiome predict heart attack outcomes?
Knowledge-focused CompletedThis study looked at the gut bacteria of 200 heart attack patients, comparing those with high blood sugar to those with normal levels. Researchers collected stool samples before treatment and again at 6 and 12 months to see if changes in gut bacteria relate to survival. The goal …
Sponsor: University of Campania Luigi Vanvitelli • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Tiny heart probe may predict lung recovery
Knowledge-focused CompletedThis study tested whether a miniaturized ultrasound probe placed in the esophagus could help predict outcomes in 50 patients with acute respiratory distress syndrome (ARDS). The probe measures a blood vessel collapse index that may indicate heart strain. Researchers tracked how m…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Lung scanner may predict breathing tube removal success
Knowledge-focused CompletedThis study tested a new way to predict if patients on breathing machines can safely have the tube removed. Researchers used a special imaging technique called electrical impedance tomography (EIT) to measure how well the lungs fill with air during a breathing trial. The goal was …
Sponsor: Ruijin Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Study aims to unlock secrets of lung failure in kids
Knowledge-focused CompletedThis study looked at 513 children with a severe lung condition called ARDS to find different subtypes of the disease. Researchers collected blood samples to measure proteins and gene activity. The goal was to better understand the disease and help design more targeted treatments …
Sponsor: Children's Hospital of Philadelphia • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:10 UTC
-
New study tracks COVID vaccine durability in chronic illness patients
Knowledge-focused CompletedThis completed study followed 360 adults and children with chronic respiratory and other medical conditions to see how their immune systems responded to COVID-19 vaccines over 18 months. Researchers measured antibody, T cell, and B cell levels before vaccination and every 3 month…
Sponsor: National Jewish Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:10 UTC
-
New tool aims to give older leukemia patients a stronger voice in treatment choices
Knowledge-focused CompletedThis pilot study tested a communication tool called UR-GOAL in 15 older adults (age 60+) with newly diagnosed acute myeloid leukemia (AML), along with their caregivers and doctors. The tool helps patients share their preferences and goals, so treatment decisions better match what…
Phase: NA • Sponsor: University of Rochester • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
Which sedative is safer for emergency intubation? a new study investigates
Knowledge-focused CompletedThis study compared two common sedatives, propofol and ketamine, used when placing a breathing tube in critically ill patients. Researchers wanted to see which drug better keeps blood pressure stable after the procedure. The trial involved 207 adults in intensive care who needed …
Phase: PHASE2 • Sponsor: Federal University of São Paulo • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
Tiny lungs, big comparison: which breathing aid works best for preemies?
Knowledge-focused CompletedThis study looked at how two different breathing devices affect the lungs of extremely low birth weight babies. Researchers compared a high-flow nasal cannula to nasal CPAP in 80 stable premature infants. They measured lung function using a special imaging technique to see which …
Phase: NA • Sponsor: Sharp HealthCare • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
Gut feeding vs. IV: which saves more lives in the ICU?
Knowledge-focused CompletedThis study looked at whether giving nutrition through a tube into the stomach (enteral) or through a vein (parenteral) early on affects survival in very sick patients who need a breathing machine and heart-support medications. Over 2,400 adults in intensive care units were random…
Phase: NA • Sponsor: Centre Hospitalier Departemental Vendee • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
New test could spot transplant rejection without a biopsy
Knowledge-focused CompletedThis study looked at whether proteins in ostomy fluid (waste from the intestine) can signal rejection after an intestinal transplant. Currently, doctors must take tissue samples through a scope to check for rejection, which is invasive and not always accurate. Researchers analyze…
Sponsor: University of California, Los Angeles • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
New ventilator approach studied in ARDS patients
Knowledge-focused CompletedThis study looked at a new way to set breathing machines for people with severe lung injury (ARDS). The method uses pressure measurements inside the lungs to adjust settings. Nine adults took part to see if the approach is safe and works well. The goal was to learn more, not to c…
Phase: NA • Sponsor: University Hospital, Angers • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
New naloxone spray tested for faster overdose help
Knowledge-focused CompletedThis study tested a new device (AP003) that delivers naloxone as a nasal spray to reverse opioid overdoses. Twenty-four healthy adults received multiple doses to see how the drug moves through the body and to check for side effects. The goal was to compare the new spray with an e…
Phase: PHASE1 • Sponsor: Emergent BioSolutions • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
New study reveals hidden kidney risks in liver cirrhosis patients
Knowledge-focused CompletedThis study looked at how often acute kidney injury happens in people with liver cirrhosis, and what factors might increase the risk. Researchers at Sohag University Hospital followed 180 adult patients with cirrhosis, excluding those with pre-existing kidney disease or other majo…
Sponsor: Sohag University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Blood test could predict leukemia survival
Knowledge-focused CompletedThis study tests whether measuring two substances in the blood—FLT3L and IL-6—during chemotherapy can help predict survival in people with acute myeloid leukemia (AML). Researchers will track 201 newly diagnosed AML patients across 25 French hospitals. The goal is to confirm that…
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Inflammation clues after heart attack could predict future risks
Knowledge-focused CompletedThis study looked at 100 people who had a heart attack to see if certain inflammation markers in the blood could predict who might die or develop heart failure within 6 months. Researchers measured these markers at several time points after the attack. The goal was to better unde…
Sponsor: Nicosia General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Nerve damage linked to kidney trouble in bypass patients
Knowledge-focused CompletedThis study looked at how a nerve condition called cardiovascular autonomic neuropathy (CAN) affects the risk of kidney injury in people having heart bypass surgery. Researchers tracked 912 adults before, during, and after surgery to see if those with CAN had worse kidney function…
Sponsor: Akdeniz University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
CAR-T therapy Follow-Up study shows no new safety surprises
Knowledge-focused CompletedThis study followed 16 people who had already received a special immune cell treatment (CLBR001 CAR-T) for various types of B-cell blood cancers like lymphoma and leukemia. The goal was to check for any new or long-term side effects that might appear months or years after treatme…
Phase: PHASE1 • Sponsor: Calibr, a division of Scripps Research • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Hunt for tick virus in limousin: 878 tested
Knowledge-focused CompletedThis completed study tested blood samples from 878 people in Limousin, France, for antibodies against tick-borne encephalitis virus (TBEV). The goal was to see if the virus is present in the region, especially in patients with Lyme disease or neurological symptoms. Researchers al…
Sponsor: University Hospital, Limoges • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Can a computer predict overdose outbreaks? rhode island trial tests new tool
Knowledge-focused CompletedThis study tested a predictive analytics tool called PROVIDENT to forecast where overdose deaths might happen next. Researchers randomly assigned 39 Rhode Island municipalities to either use the tool or continue with standard prevention efforts. The goal was to see if directing r…
Phase: NA • Sponsor: Brown University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Biomarker may forecast kidney disease risk after acute injury
Knowledge-focused CompletedThis completed study looked at whether levels of a protein called angiotensinogen in blood and urine can predict long-term kidney function in people who had acute kidney injury. Researchers followed 80 patients for three years to see if this biomarker could help identify those at…
Sponsor: Sanliurfa Mehmet Akif Inan Education and Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Blood test may forecast heart risks in shock patients
Knowledge-focused CompletedThis study looked at 264 patients who had a heart attack complicated by cardiogenic shock. Researchers examined whether the ratio of red blood cell distribution width to albumin (RAR) in the blood could predict major heart problems like death, another heart attack, or stroke duri…
Sponsor: Xuzhou Central Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Telehealth may speed heart attack care, small study suggests
Knowledge-focused CompletedThis study looked at whether a telehealth program could help paramedics treat people having a severe heart attack (STEMI) more quickly. Researchers measured times from first contact to treatment in 11 patients in Wilkes County. The goal was to see if remote support from doctors c…
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
Why do some hospitals treat baby bronchiolitis differently?
Knowledge-focused CompletedThis completed study analyzed how doctors in different hospitals treat babies under 2 years old with bronchiolitis, a common lung infection. Researchers looked at 127 children to see if differences in care led to different outcomes, like length of hospital stay. The goal was to u…
Sponsor: Hospital General de Niños Pedro de Elizalde • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
Manikin study tests best way to start CPR in kids
Knowledge-focused CompletedThis completed trial compared two ways to start CPR in a simulated child cardiac arrest: starting with chest compressions (AHA method) versus starting with rescue breaths (ERC method). Researchers used a manikin to measure how much air reached the lungs in the first minute. 28 he…
Phase: NA • Sponsor: Geneve TEAM Ambulances • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
Massive study reveals hidden toll of ICU on ARDS survivors
Knowledge-focused CompletedThis study reviewed medical records of over 640,000 people in the US who had acute respiratory distress syndrome (ARDS) and were in the ICU. Researchers wanted to find out what new health problems—physical, mental, or emotional—arise after such a stay, known as post-intensive car…
Sponsor: Bayer • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
Does extra oxygen during heart surgery protect kidneys? new pilot study investigates.
Knowledge-focused CompletedThis pilot study looked at whether giving extra oxygen during heart surgery (when a heart-lung machine is used) affects kidney function afterward. 104 adults having elective heart surgery were randomly assigned to receive either high or normal oxygen levels. The main goal was to …
Phase: NA • Sponsor: University of Padova • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
New ventilator mode tested in lung injury patients
Knowledge-focused CompletedThis study tested a new breathing machine mode called NAVA in 15 patients recovering from acute lung injury. The goal was to see how their bodies responded to different levels of support from the machine. The study did not aim to treat or cure the lung injury, but to gather infor…
Phase: NA • Sponsor: University Hospital, Caen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
Could a simple oxygen change help ICU patients breathe easier after tube removal?
Knowledge-focused CompletedThis study tested whether giving high-flow oxygen through the nose just before removing a breathing tube is safe and acceptable for patients in intensive care with severe breathing problems. Only 2 patients took part, and the main goal was to see if a larger study is possible. Th…
Phase: NA • Sponsor: NHS Greater Glasgow and Clyde • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
Deeper feeding tube may ease stomach issues in Face-Down lung patients
Knowledge-focused CompletedThis study looked at 319 adults with severe lung failure (ARDS) who were placed face-down to help them breathe. Researchers wanted to see if feeding through a tube placed past the stomach (post-pyloric) caused fewer stomach problems than standard feeding. The goal was to find the…
Sponsor: Southeast University, China • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
AI reads heart patient records faster than doctors?
Knowledge-focused CompletedThis study tested an AI system that reads medical records of 308 heart disease patients and pulls out key information like test results and diagnosis types. The AI's accuracy was compared to that of seven doctors. The goal was to see if AI can help make clinical data collection f…
Sponsor: China National Center for Cardiovascular Diseases • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC
-
Can a video call help blood cancer patients prepare for tough decisions?
Knowledge-focused CompletedThis study tested whether a telehealth program could help older patients (60+) with acute myeloid leukemia or myelodysplastic syndrome discuss and document their future medical wishes. Researchers enrolled 36 patients, caregivers, and clinicians to see if the program was easy to …
Phase: NA • Sponsor: University of Rochester • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Emergency surgery in pregnancy: new study aims to understand fetal outcomes
Knowledge-focused CompletedThis study looked at how emergency general surgery affects pregnant women and their unborn babies. Researchers planned to follow pregnant women who needed surgery for problems like appendicitis or gallbladder disease. The goal was to learn more about the safety of these surgeries…
Sponsor: Methodist Health System • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Blood protein may warn of kidney danger in sepsis
Knowledge-focused CompletedThis completed study looked at whether a protein called vasorin in the blood can help predict how severe kidney injury will be in people with septic shock. Researchers took blood samples from 50 intensive care patients on day 0 and day 3. The goal was to see if vasorin levels are…
Phase: NA • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Hospital heparin use under the microscope: did they follow the rules?
Knowledge-focused CompletedThis study looked at how well hospitals follow the standard protocol for giving heparin, a blood thinner, to patients with blood clots or heart issues. Researchers checked 100 patients to see if their heparin doses were adjusted correctly based on blood test results. The goal was…
Sponsor: Methodist Health System • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Massive global study maps kidney injury in sick kids
Knowledge-focused CompletedThis study looked at over 5,000 critically ill children from hospitals worldwide to learn more about acute kidney injury (AKI). The goal was to better understand how common AKI is, what puts children at risk, and how to predict it using a tool called 'renal angina.' The study did…
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
ER study sheds light on hidden xylazine in opioid overdoses
Knowledge-focused CompletedThis study measured the amount of xylazine—a dangerous animal sedative often mixed with opioids—in the blood and urine of 75 emergency room patients who had a non-fatal opioid overdose. The goal was to see how common xylazine is and how well test strips can detect it. The finding…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Researchers review best acyclovir dose for obese patients with rare brain infection
Knowledge-focused CompletedThis completed study reviewed medical records of 50 obese adults with HSV encephalitis (a brain infection) to see how different ways of calculating acyclovir dose affect survival. Researchers looked at patients treated between 2013 and 2019 at six hospitals. The goal was to find …
Sponsor: Methodist Health System • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Blood test may predict COVID-19 severity, study finds
Knowledge-focused CompletedThis study looked at whether a blood test measuring suPAR levels can predict which adults hospitalized with COVID-19 will develop severe breathing failure requiring a breathing tube. Researchers analyzed stored blood samples from about 367 patients. The goal was to see if a suPAR…
Sponsor: ViroGates A/S • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Heart Infection's hidden brain damage tracked over time
Knowledge-focused CompletedThis study followed 100 patients who had infectious endocarditis, a serious heart infection, to see how brain lesions found on MRI scans change over time. Researchers compared initial MRI results with follow-up scans and tested thinking and memory skills. The goal was to understa…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Ambulance blood test may speed up heart attack triage
Knowledge-focused CompletedThis study combined data from over 5,000 people to see if a simple blood test (troponin) and risk scores used by paramedics can accurately identify those having a heart attack before they reach the hospital. The goal is to improve how patients are triaged and treated early. No ne…
Phase: NA • Sponsor: Catharina Ziekenhuis Eindhoven • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
New lung monitor for tiny babies shows promise in early test
Knowledge-focused CompletedThis study tested a new device called Neola® that monitors the lungs of newborn babies. Ten preterm and term infants were enrolled to see if the device is safe and works well. The main goal was to check for any skin reactions or other side effects.
Phase: NA • Sponsor: Neola Medical AB • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Heart attack patients monitored for new AFib risk
Knowledge-focused CompletedThis completed study tracked 832 heart attack patients in China who developed new-onset atrial fibrillation during their hospital stay. Researchers used continuous heart monitoring to see how the amount of AFib affected risks like death, another heart attack, or heart failure. Th…
Sponsor: Shanghai 10th People's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Can a simple screen get seniors moving in hospital?
Knowledge-focused CompletedThis study tracked how much older adults (65+) move during a hospital stay and tested whether a screen showing real-time activity to staff could encourage more movement. Researchers also validated a Danish version of a mobility assessment. The goal is to help hospitals better sup…
Sponsor: Copenhagen University Hospital, Hvidovre • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Heart attack patients use telemedicine to stay home
Knowledge-focused CompletedThis study tested whether giving heart attack patients remote monitoring devices to use at home could reduce the need for hospital readmissions. 337 participants with high cardiovascular risk took part. The goal was to see if telemedicine could safely provide necessary diagnostic…
Phase: NA • Sponsor: Imperial College London • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC